Preparation method of nitrogen-containing polycyclic condensed ring compound and its intermediates and uses
Patent Information
- Application Number
- CN202110780873.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-07-09
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2041-07-09
AI Technical Summary
分离型家族性甲状腺髓样癌的RET胞外或胞内结构域中的重要突变之一,即激酶ATP结合位点中的看门残基V804M突变,导致现有药物对ATP结合位点亲和力下降
[0323] The preparation method of the present invention does not use the separation and purification steps of column chromatography such as silica gel column chromatography, nor does it use hydrogen as a hydrogenation or reduction reagent, which significantly improves production efficiency and safety.
Smart Images

Figure BDA0003156880710000021 
Figure BDA0003156880710000042 
Figure BDA0003156880710000051
Abstract
Description
Technical Field
[0001] The present invention relates to the field of preparation methods of pharmaceutical compounds, and in particular to preparation methods of nitrogen-containing polycyclic fused-ring compounds, intermediates thereof and uses thereof. Background Art
[0002] The RET (Rearranged During Transfection) proto-oncogene was first confirmed in 1985 by transfection of NIH3T3 (mouse embryonic fibroblast cell line) cells with human lymphoma DNA (Cell, 1985, 42 (2): 581-588). The RET proto-oncogene is located on chromosome 10q11.2, with a total DNA length of 60 kb, containing 21 exons, encoding a RET protein composed of 1,100 amino acids: This RET protein is a tyrosine kinase receptor containing an extracellular region composed of cysteine, a transmembrane region, and an intracellular region with catalytic tyrosine kinase activity (Mol Cell Endocrinol, 2010, 322 (1-2): 2-7). RET is involved in cell proliferation, nerve conduction, cell migration and cell differentiation. Through the signal of ligand / compound receptor / RET multiprotein complex, it activates various downstream pathways, such as RAS / RAF / MEK / ERK, PI3K / AKT and STAT pathways, and induces cell proliferation (J Clin Oncol, 2012, 30(2): 200-202).
[0003] RET kinase signal transduction plays an important role in many human cancers, including thyroid cancer. Among them, RET 804V mutation, the gatekeeper residue of RET, is an important cause of tumor resistance to currently approved non-selective RET inhibitors (such as cabozantinib and vandetanib). One of the important mutations in the RET extracellular or intracellular domain of isolated familial medullary thyroid carcinoma, namely the gatekeeper residue V804M mutation in the kinase ATP binding site, leads to a decrease in the affinity of existing drugs for the ATP binding site. It has been reported in the literature (RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies, Journal of Thoracic Oncology, 2020, Vol. 15, No 4, 541-549) that although the selective RET inhibitor LOXO-292 (Selpercatinib) can avoid the RET 804V mutation mentioned above, other mutations may still appear after the use of this selective RET inhibitor, leading to drug resistance. For example, in non-small cell lung cancer, it will cause the residue G810 in the solvent front of the kinase ATP binding site to mutate: such as G810R, G810S, and G801C mutations, which will lead to a decrease in LOXO-292's ATP binding site, resulting in drug resistance and cancer progression.
[0004] Patent document WO2021023209A1 discloses compounds as RET inhibitors with excellent activity or selectivity. Such compounds have strong inhibitory effects on RET gatekeeper residue mutant RET V804M, RET solvent front residue mutant G810R and other clinically relevant RET mutants and wt-RET. This type of compound can also significantly inhibit the growth of TT cell lines derived from thyroid cancer and Ba / F3 cells transformed by various RET mutants, and the inhibitory effect is good. In addition, this type of compound largely blocks cellular RET autophosphorylation and its downstream pathways, can significantly induce TT cell death, and has excellent pharmacokinetic properties. Therefore, it is necessary to develop a more efficient, more suitable for large-scale production and / or more cost-effective preparation method for such compounds, as well as an intermediate compound and a preparation method thereof to achieve the above purpose. Summary of the invention
[0005] To improve the above problems, the present invention provides a preparation method M1A of a compound of formula I, wherein the preparation method comprises reacting a compound of formula XX with R k -C(O)-H reaction to obtain a compound of formula I:
[0006]
[0007] in:
[0008] X 1 , X 2 , X 3 , X 4 The same or different, independently selected from CR 1 or N;
[0009] Each R 1 are the same or different, independently selected from H, halogen, CN, OH, unsubstituted or optionally substituted by one, two or more R a Substituted with the following groups: C 1-40 Alkyl, C 3-40 Cycloalkyl, C 1-40 Alkyloxy, C 3-40 Cycloalkyloxy, NR 2 R 3 、-C(O)R 4 , -OCR 5 、-S(O)2R 6 、OS(O)2R 7 ;
[0010] D and E are the same or different and are independently selected from H, halogen, CN, OH, -OR 21 , unsubstituted or optionally substituted with one, two or more R c Substituted with the following groups: C 1-40 Alkyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, NR 2 R 3 , provided that at least one of D and E is selected from -OR 21 ;
[0011] R 21 is selected from unsubstituted or optionally substituted with one, two or more R d Substituted with the following groups: C 1-40 Alkyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl;
[0012] G is selected from unsubstituted or optionally substituted with one, two or more R e Substituted with the following groups: C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, C 3-40 Cycloalkyloxy, C3-40 Cycloalkenyloxy, C 6-20 aryloxy, 5-20 membered heteroaryloxy or 3-20 membered heterocyclyloxy;
[0013] R k is selected from unsubstituted or optionally substituted with one, two or more R g Substituted with the following groups: C 1-40 Alkyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl;
[0014] Every R 2 The same or different, independently selected from H, C 1-40 Alkyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl, -C(O)R 4 、-S(O)2R 6 ;
[0015] Every R 3 The same or different, independently selected from H, C 1-40 Alkyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl, -C(O)R 4 、-S(O)2R 6 ;
[0016] Or, R 2 and R 3 Together with the N atom to which it is attached, it forms a 5-20 membered heteroaryl or a 3-20 membered heterocyclyl;
[0017] Every R 4 The same or different, independently selected from H, C 1-40 Alkyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, C 1-40 Alkyloxy, C 3-40 Cycloalkyloxy, C 6-20 aryloxy, 5-20 membered heteroaryloxy, 3-20 membered heterocyclyloxy, NR 2 R 3 ;
[0018] Every R 5 The same or different, independently selected from H, C 1-40 Alkyl, C 3-40 Cycloalkyl, C 6-20Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, C 1-40 Alkylcarbonyl, C 3-40 Cycloalkylcarbonyl, C 6-20 Arylcarbonyl, 5-20 membered heteroarylcarbonyl, 3-20 membered heterocyclylcarbonyl;
[0019] Every R 6 The same or different, independently selected from H, C 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, C 1-40 Alkyloxy, C 3-40 Cycloalkyloxy, C 6-20 aryloxy, 5-20 membered heteroaryloxy, 3-20 membered heterocyclyloxy, NR 2 R 3 ;
[0020] Every R 7 The same or different, independently selected from H, C 1-40 Alkyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclyl;
[0021] Every R a , R c , R d , R e are the same or different, independently selected from halogen, CN, OH, SH, oxo (=O), NO2, unsubstituted or optionally substituted by one, two or more R g Substituted with the following groups: C 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, C 1-40 Alkyloxy, C 3-40 Cycloalkyloxy, C 6-20 Aryloxy, 5-20 membered heteroaryloxy, 3-20 membered heterocyclyloxy;
[0022] Every R g are the same or different, independently selected from halogen, CN, OH, SH, oxo (=O), NO2, unsubstituted or optionally substituted by one, two or more R h Substituted with the following groups: C 1-40 Alkyl, C 2-40 Alkenyl, C2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, C 1-40 Alkyloxy, C 2-40 Alkenyloxy, C 2-40 Alkynyloxy, C 3-40 Cycloalkyloxy, C 3-40 Cycloalkenyloxy, C 3-40 Cycloalkynyloxy, C 6-20 Aryloxy, 5-20 membered heteroaryloxy, 3-20 membered heterocyclyloxy;
[0023] Every R h are the same or different and are independently selected from halogen, CN, OH, SH, oxo (=O), NO2, unsubstituted or optionally substituted by one, two or more R g Substituted with the following groups: C 1-40 Alkyl, C 2-40 Alkenyl, C 2-40 Alkynyl, C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 Cycloalkynyl, C 6-20 Aryl, 5-20 membered heteroaryl, 3-20 membered heterocyclic group, C 1-40 Alkyloxy, C 2-40 Alkenyloxy, C 2-40 Alkynyloxy, C 3-40 Cycloalkyloxy, C 3-40 Cycloalkenyloxy, C 3-40 Cycloalkynyloxy, C 6-20 Aryloxy, 5-20 membered heteroaryloxy, 3-20 membered heterocyclyloxy;
[0024] Or, when the above C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40 When different positions of the cycloalkynyl group or the 3-20-membered heterocyclic group are substituted by two or more substituents, any two of the substituents may also form a bridged ring together with the atoms to which they are connected, wherein the bridge atoms in the bridged ring except the bridgehead atom may contain 1, 2, 3, 4 or 5 divalent groups selected from CH2, O, and NH;
[0025] Alternatively, when an atom (such as a carbon atom) is substituted by two or more substituents, two of the substituents may also form a cyclic group such as C 3-40 Cycloalkyl, C 3-40 Cycloalkenyl, C 3-40Cycloalkynyl or 3-20 membered heterocyclic group, etc.
[0026] According to an embodiment of the present invention, X 1 , X 2 , X 3 , X 4 The same or different, independently selected from CR 1 or N; for example, X 1 , X 2 , X 3 , X 4 At least one of them is N, for example, X 1 , X 2 , X 3 , X 4 1, 2 or 3 of them are N;
[0027] According to an embodiment of the present invention, each R 1 are the same or different, independently selected from H, halogen, CN, OH, unsubstituted or optionally substituted by one, two or more R a Substituted with the following groups: C 1-6 Alkyl, C 3-10 Cycloalkyl, C 1-6 Alkyloxy, C 3-10 Cycloalkyloxy, for example, is selected from unsubstituted or optionally substituted with 1, 2 or 3 R a Substituted with the following groups: C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkoxy or C 3-6 Cycloalkyloxy;
[0028] According to an embodiment of the present invention, D and E are the same or different and are independently selected from H, halogen, CN, NH2, C 1-6 Alkyl or -OR 21 , provided that at least one of D and E is selected from -OR 21 ;
[0029] According to an embodiment of the present invention, at least one of D and E is selected from the following groups:
[0030] According to an embodiment of the present invention, R 2 is selected from unsubstituted or optionally substituted with one, two or more R d Substituted C 1-6 alkyl;
[0031] According to an embodiment of the present invention, each R a , R c , R dare the same or different, independently selected from halogen, CN, OH, unsubstituted or optionally substituted by one, two or more R g Substituted with the following groups: C 1-6 Alkyl, C 1-6 Alkyloxy, C 3-10 Cycloalkyl, C 3-10 Cycloalkyloxy;
[0032] According to an embodiment of the present invention, each R g are the same or different and are independently selected from halogen or C 3-10 Cycloalkyl;
[0033] According to an embodiment of the present invention, G is selected from C 3-10 Cycloalkyl, C 6-14 Aryl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group, for example, 6-7 membered heterocyclic group having a monocyclic, bicyclic, or bridged ring structure, which may contain 1, 2, or 3 heteroatoms independently selected from N, O, and S;
[0034] According to an embodiment of the present invention, R k is selected from unsubstituted or optionally substituted with one, two or more R g Substituted with the following groups: C 3-10 Cycloalkyl, C 6-14 Aryl, 5-14 membered heteroaryl, 3-10 membered heterocyclic group; wherein the heteroaryl group may be a pyridyl group, for example, selected from pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridin-5-yl, pyridin-6-yl; the aryl group may be a phenyl group.
[0035] According to an exemplary embodiment of the present invention, wherein X 1 , X 2 , X 3 , X 4 are the same or different and are independently selected from CH or N; for example, X 1 , X 2 , X 3 , X 4 At least one of them is N, for example, X 1 , X 2 , X 3 , X 4 1, 2 or 3 of them are N;
[0036] According to an exemplary embodiment of the present invention, R 1 is H;
[0037] According to an exemplary embodiment of the present invention, E is H;
[0038] According to an exemplary embodiment of the present invention, D is selected from the following groups: halogen, BnO-, H, -CN, -NH2, -OCH3, and the following groups:
[0039]
[0040]
[0041] According to an exemplary embodiment of the present invention, G is selected from
[0042] According to an exemplary embodiment of the present invention, R k is selected from unsubstituted or optionally substituted with one, two or more R g Substituted pyridyl or phenyl, wherein when there are one, two or more R g When substituted, the R g Substitution can be performed on the 1, 2, 3, 4, 5, or 6 position of the pyridine or phenyl group as long as it does not affect the R k The connection with the group G can be via a methylene group.
[0043] As an example, R k Can form with methylene a group selected from the following:
[0044] Alternatively, R k Can be selected from 1, 2, 3 or 4 selected from C 1-6 Alkyl and C 1-6 Alkyloxy substituted groups
[0045] According to an exemplary embodiment of the present invention, the compound of formula I can be selected from the following compounds:
[0046]
[0047]
[0048]
[0049] As an example, the compound of formula I is selected from the following compounds:
[0050]
[0051]
[0052] According to an embodiment of the present invention, the compound of formula XX and R kThe reaction of -C(O)-H can be carried out in the presence of borane, pyridine borane, 2-methylpyridine borane (Pic-BH3), sodium borohydride, sodium triacetoxyborohydride, sodium cyanoborohydride, preferably in the presence of 2-methylpyridine borane.
[0053] According to an embodiment of the present invention, the compound of formula XX and R k The reaction of -C(O)-H can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is an organic solvent such as 1,2-dimethyl-2-nitropropanol, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidine, octyl pyrrolidine, octyl caprolactam, 1,3-dimethyl-2-imidazolidinedione, N-formyl piperidine or N,N'-1,4-diformyl piperazine); nitriles (such as acetonitrile, propionitrile, n-butyronitrile, isobutyronitrile or benzonitrile); alcohols (such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol or tert-butanol); ketones (such as acetone, N-methylpyrrolidone). Preferably, the organic solvent is n-propanol.
[0054] According to an embodiment of the present invention, in the method for preparing the compound of formula I, the compound of formula XX and R k The molar ratio of -C(O)-H may be from 1:1 to 1:5, preferably from 1:1.1 to 1:1.3.
[0055] According to an embodiment of the present invention, in the method for preparing the compound of formula I, the molar ratio of the compound of formula XX to borane or 2-methylpyridine borane can be 1:1 to 1:5, preferably 1:1.1 to 1:1.3.
[0056] According to an embodiment of the present invention, in the method for preparing the compound of formula I, the molar ratio of the compound of formula XX to the base can be 1:1 to 1:5, preferably 1:1.5 to 1:3.5, such as 1:1.8 to 1:2.2.
[0057] According to an embodiment of the present invention, the reaction temperature of the method for preparing the compound of formula I may be 15 to 50° C., for example 20 to 30° C., such as room temperature.
[0058] According to an embodiment of the present invention, the compound of formula XX can also be reacted in the form of its salt (such as an acid addition salt) as a raw material. Preferably, when the salt form of the compound of formula XX is used for the reaction, a base can be used to free it to form the compound of formula XX. The freeing can be carried out alone or in a "one-pot" manner with the reaction in the above-mentioned preparation method M1A.
[0059] According to an embodiment of the present invention, the base may be an organic base or an inorganic base, for example:
[0060] An organic base selected from the group consisting of a tertiary amine, a substituted or unsubstituted pyridine, and a substituted or unsubstituted triethylamine, trimethylamine, N,N-diisopropylethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-hexylamine, tricyclohexylamine, N-methylcyclohexylamine, N-methylpyrrolidine, N-methylpyrrolidone, N-methylpiperidine, N-ethylpiperidine, N,N-dimethylaniline, N-methylmorpholine, pyridine, 2,3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 2,6-dimethylpyridine, pyridine, 2,4,6-trimethylpyridine, 4-dimethylaminopyridine, quinoline, methylquinoline, N,N,N,N-tetramethylethylenediamine, N,N-dimethyl-1,4-diazacyclohexane, N,N-diethyl-1,4-diazacyclohexane, 1,8-bis(dimethylamino)naphthalene, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), butylimidazole, methylimidazole, sodium tert-butoxide, potassium tert-butoxide; or
[0061] An inorganic base selected from the group consisting of alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates and bicarbonates, such as sodium amide, sodium hydride, lithium diisopropylamide, sodium methoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate and cesium carbonate.
[0062] According to an exemplary embodiment of the present invention, the preparation method M1A comprises preparing compound 1 by subjecting compound 20 to the following reaction:
[0063]
[0064] The present invention also provides compounds of the above formula XX, for example, compound 20.
[0065] The present invention also provides the use of the above-mentioned compound of formula XX (eg, compound 20) in the preparation of a compound of formula I (eg, compound 1).
[0066] The present invention also provides a compound of the following formula XIX:
[0067]
[0068] in:
[0069] G is selected from unsubstituted or optionally substituted with one, two or more R e The following groups substituted: 5-20 membered heteroaryl, 3-20 membered heterocyclyl, 5-20 membered heteroaryloxy or 3-20 membered heterocyclyloxy, wherein G has at least 1 N atom and the N atom is substituted with PG 19 connect;
[0070] X 1 , X 2 , X 3 , X 4 , D, E, R e independently having the definitions set out above;
[0071] PG 19 It is an amino protecting group.
[0072] According to an embodiment of the present invention, PG 19 It can be selected from amino protecting groups known to those skilled in the art, such as tert-butyloxycarbonyl (Boc), cyclobutyloxycarbonyl, benzyloxycarbonyl (CBz), p-methoxybenzylcarbonyl (Moz), 2-biphenyl-2-propyloxycarbonyl (BPoc), 2,2,2-trichloroethoxycarbonyl (Troc), phthalimido, p-toluenesulfonyl, trifluoroacetyl, (9H-fluoren-9-ylmethoxy)carbonyl (Fmoc), benzyl, 4-methoxybenzyl, diphenylmethyl, 2-(trimethylsilyl)ethoxycarbonyl (Teoc), adamantyloxycarbonyl (Adoc), formyl, acetyl, and the like.
[0073] The present invention also provides a preparation method M20 of a compound of formula XX, comprising removing PG from a compound of formula XIX. 19 The reaction is carried out under the conditions of to obtain a compound of formula XX.
[0074] De-PG of the compound of formula XIX 19 The conditions are known to those skilled in the art for removing amino protecting groups. For example, the PG of the compound of formula XIX can be removed in the presence of an acid. 19 The acid can be selected from one, two or more inorganic acids or organic acids such as hydrochloric acid, sulfuric acid, formic acid, acetic acid, etc.
[0075] According to an embodiment of the present invention, in the method for preparing the compound of formula XX, the molar ratio of the compound of formula XIX to the acid may be 1:1 to 1:5, such as 1:3 to 1:4.
[0076] According to an embodiment of the present invention, the compound of formula XIX is freed from PG 19 The reaction can be carried out in the presence of an organic solvent. The organic solvent has the definition as described above, for example, an alcohol solvent, such as one, two or more selected from methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol and tert-butanol.
[0077] According to an embodiment of the present invention, the reaction temperature of the method for preparing the compound of formula I may be 40 to 70°C, such as 50 to 60°C.
[0078] According to an embodiment of the present invention, the preparation method M20 comprises preparing compound 20 by subjecting compound 19 to the following reaction:
[0079]
[0080] Therefore, the present invention also provides compound 19.
[0081] The present invention also provides the use of the above-mentioned compound of formula XIX (eg compound 19) in the preparation of a compound of formula XX (eg compound 20).
[0082] The present invention also provides a compound of the following formula XI:
[0083]
[0084] in:
[0085] D and E independently have the definitions given above;
[0086] L 11 is selected from leaving groups, for example the following groups which are unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens: C 1-6 Alkylsulfonyloxy, C 1-6 Alkylbenzenesulfonyloxy such as methanesulfonyloxy (MsO-), trifluoromethanesulfonyloxy (TfO-), p-toluenesulfonyloxy (TsO-), halogen (such as F, Cl, Br or I).
[0087] The present invention also provides a compound of the following formula XVIII:
[0088]
[0089] Among them, X 1 , X 2 , X 3 , X 4 , G, PG 19 Independently have the definitions given above.
[0090] The present invention also provides a preparation method M19A of a compound of formula XIX, comprising reacting a compound of formula XI with a compound of formula XVIII to obtain a compound of formula XIX:
[0091]
[0092] Among them, X 1 , X 2 , X 3 , X 4 , D, E, G, L 11 PG 19 Independently have the definitions given above.
[0093] According to an embodiment of the present invention, in the method for preparing the compound of formula XIX, the reaction may be carried out in the presence of a base.
[0094] The base can be an organic base or an inorganic base, for example:
[0095] An organic base selected from the group consisting of a tertiary amine, a substituted or unsubstituted pyridine, and a substituted or unsubstituted triethylamine, trimethylamine, N,N-diisopropylethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-hexylamine, tricyclohexylamine, N-methylcyclohexylamine, N-methylpyrrolidine, N-methylpyrrolidone, N-methylpiperidine, N-ethylpiperidine, N,N-dimethylaniline, N-methylmorpholine, pyridine, 2,3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 2,6-dimethylpyridine, pyridine, 2,4,6-trimethylpyridine, 4-dimethylaminopyridine, quinoline, methylquinoline, N,N,N,N-tetramethylethylenediamine, N,N-dimethyl-1,4-diazacyclohexane, N,N-diethyl-1,4-diazacyclohexane, 1,8-bis(dimethylamino)naphthalene, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), butylimidazole, methylimidazole, sodium tert-butoxide, potassium tert-butoxide; or
[0096] An inorganic base selected from the group consisting of alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates and bicarbonates, such as sodium amide, sodium hydride, lithium diisopropylamide, sodium methoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate and cesium carbonate.
[0097] According to an embodiment of the present invention, the preparation method of the compound of formula XIX can be carried out in the presence of an organic solvent or a mixed solvent of an organic solvent and water. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is an organic solvent such as 1,2-dimethyl-2-nitropropane, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidine, octyl pyrrolidine, octyl caprolactam, 1,3-dimethyl-2-imidazolidinedione, N-formyl piperidine or N,N'-1,4-diformyl piperazine); nitriles (such as acetonitrile, propionitrile, n-butyronitrile, isobutyronitrile or benzonitrile); alcohols (such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol or tert-butanol); ketones (such as acetone, N-methylpyrrolidone). Preferably, the organic solvent is dioxane.
[0098] According to an embodiment of the present invention, the preparation method of the compound of formula XIX can be carried out in the presence of a catalyst, and the catalyst can be a palladium catalyst, such as Pd(dba)2, PdCl2, Pd(OAc)2, Pd(dppf)Cl2, Pd2(dba)3, PdCl2(CH3CN)2, Pd(PPh3)4, PdCl2(PPh3)2, Pd(t-Bu)3, PdCl2(PPh3)2·CH2Cl2, Pd(OAc) / PPh3, PdCl2[(Pet3)]2, Pd(DIPHOS)2, Pd(P ... dCl2(Bipy), [PdCl(Ph2PCH2PPh2)]2, PdCl2[P(o-Tol)3]2, Pd2(dba)3 / P(o-Tol)3, Pd2(dba) / P(furyl)3, PdCl2[P(furyl)3]2, PdCl2(PMePh2)2, PdCl2[P(4-F-Ph)3]2, PdCl2[P(C6F6)3]2, PdCl2[P(2-COOH-Ph)(Ph)2]2, PdCl2[P(4-COOH-Ph)(Ph)2]2.
[0099] According to an embodiment of the present invention, the reaction temperature of the method for preparing the compound of formula XIX can be above 50°C, for example above 80°C, such as 85°C.
[0100] According to an embodiment of the present invention, in the method for preparing the compound of formula XIX, the molar ratio of the compound of formula XI to the compound of formula XVIII can be 1:1 to 1:2, for example, 1:1.1 to 1:1.3, such as 1:1.2 to 1:1.3.
[0101] According to an embodiment of the present invention, in the method for preparing the compound of formula XIX, the molar ratio of the compound of formula XI to the base can be 1:1 to 1:5, for example, 1:1.5 to 1:3.5, such as 1:1.8 to 1:2.2.
[0102] According to an embodiment of the present invention, in the method for preparing the compound of formula XIX, the molar ratio of the compound of formula XI to the catalyst may be 1:0.001 to 1:0.05, such as 1:0.02 to 1:0.03.
[0103] According to an embodiment of the present invention, the preparation method M19A comprises preparing compound 19 by reacting compound 11 and compound 18 as follows:
[0104]
[0105] Therefore, the present invention also provides the above-mentioned compound 11 or compound 18.
[0106] The present invention also provides use of the above-mentioned compound of formula XI (eg compound 11) and / or compound of formula XVIII (eg compound 18) in the preparation of a compound of formula XIX (eg compound 19).
[0107] The present invention also provides a preparation method M11 of a compound of formula XI, comprising reacting a compound of formula X with hydrazine (such as hydrazine hydrate) to obtain a compound of formula XI:
[0108]
[0109] in:
[0110] D, E, L 11 independently having the definitions set out above;
[0111] L 10 is selected from a leaving group, for example a halogen, such as F, Cl, Br or I.
[0112] According to an embodiment of the present invention, the preparation method of the compound of formula XI can be carried out in the presence of an organic solvent or a mixed solvent of an organic solvent and water. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is dimethyl sulfoxide.
[0113] According to an embodiment of the present invention, in the method for preparing the compound of formula XI, the reaction temperature may be above 100°C, such as 110-115°C.
[0114] According to an embodiment of the present invention, in the method for preparing the compound of formula XI, the molar ratio of the compound of formula X to hydrazine can be 1:1 to 1:15, for example, 1:2 to 1:10, such as 1:6 to 1:8.
[0115] According to an embodiment of the present invention, the preparation method M11 comprises preparing compound 11 by reacting compound 10 as follows:
[0116]
[0117] The present invention also provides the compound of the above formula X, for example, compound 10.
[0118] The present invention also provides the use of the above-mentioned compound of formula X (eg compound 10) in preparing a compound of formula XI (eg compound 11).
[0119] The present invention also provides a preparation method M10A of a compound of formula X, comprising reacting a compound of formula XIII with a compound R 21 -L 13 Reaction to obtain a compound of formula X:
[0120]
[0121] in:
[0122] D.L 10 , L 11 , R 21 independently having the definitions set out above;
[0123] E is selected from -OR 21 ;
[0124] L 13 is selected from leaving groups, such as halogen, such as the following groups which are unsubstituted or substituted by 1, 2, 3, 4, 5 or 6 halogens: C 1-6 Alkylsulfonyloxy, C 1-6 Alkylbenzenesulfonyloxy, such as methanesulfonyloxy (MsO-), trifluoromethanesulfonyloxy (TfO-), p-toluenesulfonyloxy (TsO-), F, Cl, Br or I.
[0125] According to an embodiment of the present invention, the preparation method of the compound of formula X can be carried out in the presence of a base.
[0126] According to an embodiment of the present invention, the base may be an organic base or an inorganic base, for example:
[0127] An organic base selected from the group consisting of a tertiary amine, a substituted or unsubstituted pyridine, and a substituted or unsubstituted triethylamine, trimethylamine, N,N-diisopropylethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-hexylamine, tricyclohexylamine, N-methylcyclohexylamine, N-methylpyrrolidine, N-methylpyrrolidone, N-methylpiperidine, N-ethylpiperidine, N,N-dimethylaniline, N-methylmorpholine, pyridine, 2,3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 2,6-dimethylpyridine, pyridine, 2,4,6-trimethylpyridine, 4-dimethylaminopyridine, quinoline, methylquinoline, N,N,N,N-tetramethylethylenediamine, N,N-dimethyl-1,4-diazacyclohexane, N,N-diethyl-1,4-diazacyclohexane, 1,8-bis(dimethylamino)naphthalene, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), butylimidazole, methylimidazole, sodium tert-butoxide, potassium tert-butoxide; or
[0128] An inorganic base selected from the group consisting of alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates and bicarbonates, such as sodium amide, sodium hydride, lithium diisopropylamide, sodium methoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate and cesium carbonate.
[0129] According to an embodiment of the present invention, the preparation method of the compound of formula X can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is selected from dimethyl sulfoxide or N,N-dimethylformamide.
[0130] According to an embodiment of the present invention, in the method for preparing the compound of formula X, the compound of formula XIII and the compound R 21 -L 13 The molar ratio of may be 1:1 to 1:2, for example 1:1 to 1:1.2, such as 1:1 to 1:1.1.
[0131] According to an embodiment of the present invention, in the method for preparing the compound of formula X, the molar ratio of the compound of formula XIII to the base can be 1:1 to 1:2, for example, 1:1.1 to 1:1.3, such as 1:1.1 to 1:1.2.
[0132] According to an embodiment of the present invention, the reaction temperature in the method for preparing the compound of formula X may be above 50°C, for example, 60-70°C, such as 65°C.
[0133] According to an embodiment of the present invention, the preparation method M10A comprises preparing compound 10 by reacting compound 13 as follows:
[0134]
[0135] The present invention also provides the compound of the above formula XIII, for example, compound 13.
[0136] The present invention also provides the use of the above-mentioned compound of formula XIII (eg compound 13) in the preparation of a compound of formula X (eg compound 10).
[0137] The present invention also provides a preparation method M13 of a compound of formula XIII, comprising reacting a compound of formula IIIB in the presence of phosphorus oxychloride (POCl3), wherein the compound of formula IIIB has the following structure:
[0138]
[0139] in:
[0140] L 10 , L 11 independently having the definitions set out above;
[0141] PG 3 is selected from hydroxy protecting groups.
[0142] According to an embodiment of the present invention, PG 3 It can be selected from hydroxy protecting groups known to those skilled in the art, for example, unsubstituted or optionally substituted with 1, 2, 3, 4 or 5 groups selected from C 1-6 Alkyl, C 1-6 The following groups substituted by alkyloxy, halogen: benzyl, C 1-6 Alkyl, tri(C 1-6 alkyl)silyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, allyl, triphenylmethyl, C 1-6 Alkyloxymethyl, benzyloxymethyl, C 1-6 Alkylcarbonyl, haloC 1-6 Alkylcarbonyl, benzoyl, examples of which may be selected from benzyl, 4-methoxybenzyl, 4-methylbenzyl, 4-chlorobenzyl, 4-bromobenzyl or 2,3,4-trimethoxybenzyl.
[0143] According to an embodiment of the present invention, the preparation method M13 comprises reacting compound 3b in the presence of phosphorus oxychloride (POCl3), wherein compound 3b has the following structure:
[0144]
[0145] According to an embodiment of the present invention, in the preparation method of the compound of formula XIII, the compound of formula IIIB (e.g., compound 3b) can first react with phosphorus oxychloride to obtain a compound of formula XII, and then the compound of formula XII is further reacted to obtain a compound of formula XIII, wherein the compound of formula XII has the following structure:
[0146]
[0147] Among them, L 10 , L 11 PG 3 Independently have the definitions given above.
[0148] According to an embodiment of the present invention, in the method for preparing the compound of formula XIII, the molar ratio of the compound of formula IIIB to phosphorus oxychloride can be 1:2 to 1:4, for example 1:2 to 1:3, such as 1:2.4 to 1:2.5.
[0149] According to an embodiment of the present invention, the preparation method of the compound of formula XIII can be carried out in a one-pot process.
[0150] According to an embodiment of the present invention, the reaction solvent for the reaction of the compound of formula IIIB with phosphorus oxychloride to obtain the compound of formula XII may be the above-mentioned organic solvent, such as N,N-dimethylformamide.
[0151] According to an embodiment of the present invention, the reaction temperature for reacting the compound of formula IIIB with phosphorus oxychloride to obtain the compound of formula XII may be -5°C to 80°C, such as 0 to 70°C.
[0152] According to an embodiment of the present invention, the reaction solvent for further reacting the compound of formula XII to obtain the compound of formula XIII may be a mixed solvent of the above-mentioned organic solvent and water, such as a mixed solvent of N,N-dimethylformamide and water.
[0153] According to an embodiment of the present invention, the reaction temperature for further reacting the compound of formula XII to obtain the compound of formula XIII may be 15 to 40°C, for example 20 to 35°C, such as 25 to 30°C.
[0154] According to an embodiment of the present invention, the preparation method M13 comprises preparing compound 12 from compound 3b, and preparing compound 13 from compound 12 by the following reaction:
[0155]
[0156] The present invention also provides the compound of formula IIIB, for example, compound 3b.
[0157] The present invention also provides the compound of the above formula XII, for example, compound 12.
[0158] The present invention also provides the use of the above-mentioned compound of formula IIIB (eg compound 3b) and / or compound of formula XII (eg compound 12) in the preparation of a compound of formula XIII (eg compound 13).
[0159] The present invention also provides the use of the above-mentioned compound of formula IIIB (eg compound 3b) in the preparation of a compound of formula XII (eg compound 12).
[0160] The present invention also provides a preparation method M10B of a compound of formula X, comprising reacting a compound of formula XVII with phosphorus oxychloride to obtain a compound of formula X:
[0161]
[0162] Among them, D, E, L 10 , L 11 Independently have the definitions given above.
[0163] According to an embodiment of the present invention, the preparation method of the compound of formula X can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is selected from dimethyl sulfoxide or N,N-dimethylformamide.
[0164] According to an embodiment of the present invention, in the method for preparing the compound of formula X, the molar ratio of the compound of formula XVII to phosphorus oxychloride can be 1:2 to 1:8, for example 1:3 to 1:6, for example 1:4 to 1:5:2 to 1:4, for example 1:2 to 1:3, for example 1:2.4 to 1:2.5.
[0165] According to an embodiment of the present invention, the preparation method M10B comprises preparing compound 10 by reacting compound 17 as follows:
[0166]
[0167] The present invention also provides the compound of the above formula XVII, for example, compound 17.
[0168] The present invention also provides use of the compound of formula XVII (eg compound 17) in preparing a compound of formula X (eg compound 10).
[0169] The present invention also provides a preparation method M17 of the compound of formula XVII, comprising reacting the compound of formula XVI with an alkali metal halide or an organic halide to obtain the compound of formula XVII:
[0170]
[0171] Among them, D, E, L 10 independently having the definitions set out above;
[0172] L 16 is the following group which is unsubstituted or substituted by 1, 2, 3, 4, 5 or 6 halogens: C 1-6 Alkylsulfonyl, C 1-6 Alkylbenzenesulfonyl groups, such as methanesulfonyl (Ms-), trifluoromethanesulfonyl (Tf-), p-toluenesulfonyl (Ts-).
[0173] According to an embodiment of the present invention, in the method for preparing the compound of formula XVII, the alkali metal halide or organic halide salt can be selected from at least one of LiBr, NaBr, KBr, CsBr, and Bu4NBr.
[0174] According to an embodiment of the present invention, the preparation method of the compound of formula XVII can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, and ethylene oxide and sulfoxides (e.g. tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (e.g. dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (e.g. pentane, hexane, heptane, octane, nonane, cyclohexane , methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example, chlorobenzene or dichlorobenzene); amides (for example, hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Caprolactam, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidine, octyl pyrrolidine, octyl caprolactam, 1,3-dimethyl-2-imidazolidinedione, N-formyl piperidine or N,N'-1,4-diformyl piperazine); nitriles (such as acetonitrile, propionitrile, n-butyronitrile, isobutyronitrile or benzonitrile); alcohols (such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol or tert-butanol); ketones (such as acetone, N-methylpyrrolidone). Preferably, the organic solvent is n-propanol.
[0175] According to an embodiment of the present invention, in the method for preparing the compound of formula XVII, the molar ratio of the compound of formula XVI to the alkali metal halide or organic halide salt can be 1:1 to 1:5, for example 1:1 to 1:2, such as 1:1.5.
[0176] According to an embodiment of the present invention, the preparation method of the compound of formula XVII can be carried out in the presence of a catalyst. The catalyst is for example pentamethylcyclopentadiene ditriphenylphosphine ruthenium (II) chloride, tris(acetonitrile) pentamethylcyclopentadiene trifluoromethanesulfonate ruthenium (II), pentamethylcyclopentadienyl tris(acetonitrile) ruthenium hexafluorophosphate (II), (pentamethylcyclopentadienyl) ruthenium (II) chloride (dimer), (pentamethylcyclopentadienyl) ruthenium (I) chloride (tetramer), tris(acetonitrile) tetramethylcyclopentadiene trifluoromethanesulfonate ruthenium (II), cyclooctadiene dichloride ruthenium (II).
[0177] According to an embodiment of the present invention, in the method for preparing the compound of formula XVII, the molar ratio of the compound of formula XVI to the catalyst may be 1:0.01 to 1:0.1, such as 1:0.05.
[0178] According to an embodiment of the present invention, the reaction temperature of the method for preparing the compound of formula XVII may be above 50°C, for example above 80°C, such as 90 to 100°C.
[0179] According to an embodiment of the present invention, the preparation method M17 comprises preparing compound 17 by reacting compound 16 as follows:
[0180]
[0181] The present invention also provides the compound of the above formula XVI, for example, compound 16.
[0182] The present invention also provides the use of the above-mentioned compound of formula XVI (eg compound 16) in the preparation of a compound of formula XVII (eg compound 17).
[0183] The present invention also provides a preparation method M16 of a compound of formula XVI, comprising reacting a compound of formula XV with a sulfonylating agent to obtain a compound of formula XVI:
[0184]
[0185] Among them, D, E, L 10 Independently have the definitions given above.
[0186] According to an embodiment of the present invention, the preparation method of the compound of formula XVI can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is selected from dichloromethane.
[0187] According to an embodiment of the present invention, in the method for preparing the compound of formula XVI, the sulfonylating agent can be selected from C 1-6 Alkylsulfonyl chloride, unsubstituted or substituted by 1, 2, 3, 4, 5 or 6 halogens 1-6 Alkylsulfonic anhydride, unsubstituted or substituted by 1, 2, 3, 4, 5 or 6 halogens 1-6 Alkylbenzenesulfonyl chloride, such as one of methanesulfonyl chloride, methanesulfonic anhydride, trifluoromethanesulfonyl chloride, trifluoromethanesulfonic anhydride, p-toluenesulfonyl chloride, p-toluenesulfonic anhydride and 1,1,1-trifluoro-N-phenyl-N-((trifluoromethyl)sulfonyl)methanesulfonamide (PhN(Tf)2).
[0188] According to an embodiment of the present invention, in the method for preparing the compound of formula XVI, the molar ratio of the compound of formula XV to the sulfonylating agent can be 1:1 to 1:5, for example 1:1 to 1:1.2, such as 1:1.1 to 1:1.15.
[0189] According to an embodiment of the present invention, the preparation method M16 comprises preparing compound 16 by reacting compound 15 as follows:
[0190]
[0191] The present invention also provides compounds of the above formula XV, for example, compound 15.
[0192] The present invention also provides the use of the above-mentioned compound of formula XV (eg compound 15) in the preparation of a compound of formula XVI (eg compound 16).
[0193] The present invention also provides a preparation method M15 of a compound of formula XV, comprising reacting a compound of formula XIV with an acid to obtain a compound of formula XV:
[0194]
[0195] Among them, D, E, L 10 PG 3 Independently have the definitions given above.
[0196] According to an embodiment of the present invention, in the method for preparing the compound of formula XV, the acid can be selected from at least one of an organic acid or an inorganic acid, such as hydrochloric acid, hydrobromic acid, hydroiodic acid, phosphoric acid, sulfuric acid, methanesulfonic acid, trifluoromethanesulfonic acid, trimethylsilyl trifluoromethanesulfonate, trifluoroacetic acid, phosphorus oxychloride, succinic acid, and ascorbic acid.
[0197] According to an embodiment of the present invention, the preparation method of the compound of formula XV can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is selected from dichloromethane.
[0198] According to an embodiment of the present invention, in the method for preparing the compound of formula XV, the molar ratio of the compound of formula XIV to trifluoroacetic acid can be 1:1 to 1:10, for example 1:4 to 1:6, such as 1:5 to 1:5.5.
[0199] According to an embodiment of the present invention, in the method for preparing the compound of formula XV, trifluoroacetic acid can be added dropwise to participate in the reaction.
[0200] According to an embodiment of the present invention, the preparation method M15 comprises preparing compound 15 by reacting compound 14 as follows:
[0201]
[0202] The present invention also provides the compound of the above formula XIV, for example, compound 14.
[0203] The present invention also provides use of the compound of formula XIV (eg compound 14) in preparing a compound of formula XV (eg compound 15).
[0204] The present invention also provides a preparation method M14 of a compound of formula XIV, comprising reacting a compound of formula IIIA with ethanol to obtain a compound of formula XIV:
[0205]
[0206] Among them, D, L 10 PG 3 independently having the definitions set out above;
[0207] L 3a is selected from a leaving group, for example a halogen, such as chlorine, bromine or iodine.
[0208] According to an embodiment of the present invention, the preparation method of the compound of formula XIV can be carried out in the presence of a copper catalyst and a ligand.
[0209] According to an embodiment of the present invention, the copper catalyst may be selected from at least one of cuprous iodide (CuI), cuprous bromide (CuBr), and copper acetylacetonate (Cu(acac)2).
[0210] According to an embodiment of the present invention, the ligand can be selected from at least one of N1,N2-bis(4-hydroxy-2,6-dimethylphenyl)oxalamide, 8-hydroxyquinoline, N,N'-bis(2,4,6-trimethoxyphenyl)oxalamide, N-benzyl-N-(2-methylnaphthalene-1-yl)oxalamide, and N1,N2-bis(4-hydroxy-2,6-dimethylphenyl)oxalamide.
[0211] According to an embodiment of the present invention, the preparation method of the compound of formula XIV can be further carried out in the presence of a base. The base can be an organic base or an inorganic base, for example:
[0212] An organic base selected from the following: tertiary amine, substituted or unsubstituted pyridines and substituted or unsubstituted triethylamine, trimethylamine, N,N-diisopropylethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-hexylamine, tricyclohexylamine, N-methylcyclohexylamine, N-methylpyrrolidine, N-methylpiperidine, N-ethylpiperidine, N,N-dimethylaniline, N-methylmorpholine, pyridine, 2,3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 2,6-lutidine, 2,4,6-Trimethylpyridine, 4-dimethylaminopyridine, quinoline, methylquinoline, N,N,N,N-tetramethylethylenediamine, N,N-dimethyl-1,4-diazacyclohexane, N,N-diethyl-1,4-diazacyclohexane, 1,8-bis(dimethylamino)naphthalene, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), butylimidazole, methylimidazole, sodium tert-butoxide, potassium tert-butoxide; or
[0213] An inorganic base selected from the group consisting of alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates and bicarbonates, such as sodium amide, sodium hydride, lithium diisopropylamide, sodium methoxide, potassium tert-butoxide, sodium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate and cesium carbonate.
[0214] According to an embodiment of the present invention, in the method for preparing the compound of formula XIV, the molar volume ratio of the compound of formula IIIA to ethanol can be 1 mol:(2-5)L, such as 1 mol:(3-4)L.
[0215] According to an embodiment of the present invention, in the method for preparing the compound of formula XIV, the molar ratio of the compound of formula IIIA to the cuprous catalyst may be 1:0.01 to 1:0.2, such as 1:0.02.
[0216] According to an embodiment of the present invention, in the method for preparing the compound of formula XIV, the molar ratio of the compound of formula IIIA to the base can be 1:1 to 1:10, such as 1:2 to 1:4, such as 1:3.
[0217] According to an embodiment of the present invention, in the method for preparing the compound of formula XIV, the molar ratio of the compound of formula IIIA to the ligand may be 1:0.01 to 1:0.2, such as 1:0.02.
[0218] According to an embodiment of the present invention, in the method for preparing the compound of formula XIV, the reaction temperature may be above 50°C, for example above 70°C, such as 80 to 100°C.
[0219] According to an embodiment of the present invention, the preparation method M14 comprises preparing compound 14 by reacting compound 3a as follows:
[0220]
[0221] The present invention also provides the compound of formula IIIA, for example, compound 3a.
[0222] The present invention also provides use of the above-mentioned compound of formula IIIA (eg, compound 3a) in preparing a compound of formula XIV (eg, compound 14).
[0223] The present invention also provides a preparation method M10C of a compound of formula X, comprising reacting a compound of formula IX with an alkali metal halide or an organic halide salt to obtain a compound of formula X:
[0224]
[0225] Among them, D, E, L 10 , L 16 Independently have the definitions given above.
[0226] According to an embodiment of the present invention, in the method for preparing the compound of formula X, the alkali metal halide or organic halide salt can be selected from at least one of LiBr, NaBr, KBr, CsBr, and Bu4NBr.
[0227] According to an embodiment of the present invention, the preparation method of the compound of formula X can be carried out in the presence of a base. The base can be an organic base or an inorganic base, for example:
[0228] An organic base selected from the group consisting of a tertiary amine, a substituted or unsubstituted pyridine, and a substituted or unsubstituted triethylamine, trimethylamine, N,N-diisopropylethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-hexylamine, tricyclohexylamine, N-methylcyclohexylamine, N-methylpyrrolidine, N-methylpyrrolidone, N-methylpiperidine, N-ethylpiperidine, N,N-dimethylaniline, N-methylmorpholine, pyridine, 2,3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 2,6-dimethylpyridine, pyridine, 2,4,6-trimethylpyridine, 4-dimethylaminopyridine, quinoline, methylquinoline, N,N,N,N-tetramethylethylenediamine, N,N-dimethyl-1,4-diazacyclohexane, N,N-diethyl-1,4-diazacyclohexane, 1,8-bis(dimethylamino)naphthalene, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), butylimidazole, methylimidazole, sodium tert-butoxide, potassium tert-butoxide; or
[0229] An inorganic base selected from the group consisting of alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates and bicarbonates, such as sodium amide, sodium hydride, lithium diisopropylamide, sodium methoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate and cesium carbonate.
[0230] According to an embodiment of the present invention, in the method for preparing the compound of formula X, the molar ratio of the compound of formula IX to the alkali metal halide or organic halide salt can be 1:1 to 1:5, for example 1:1 to 1:2, such as 1:1.5.
[0231] According to an embodiment of the present invention, the preparation method of the compound of formula X can be carried out in the presence of a catalyst. The catalyst is, for example, pentamethylcyclopentadiene ditriphenylphosphine ruthenium (II) chloride, tris(acetonitrile) pentamethylcyclopentadiene trifluoromethanesulfonate ruthenium (II), pentamethylcyclopentadienyl tris(acetonitrile) ruthenium hexafluorophosphate (II), (pentamethylcyclopentadienyl) ruthenium (II) chloride (dimer), (pentamethylcyclopentadienyl) ruthenium (I) chloride (tetramer), tris(acetonitrile) tetramethylcyclopentadiene trifluoromethanesulfonate ruthenium (II), cyclooctadiene dichloride ruthenium (II). .
[0232] According to an embodiment of the present invention, in the method for preparing the compound of formula X, the molar ratio of the compound of formula IX to the catalyst may be 1:0.01 to 1:0.1, such as 0.05.
[0233] According to an embodiment of the present invention, the reaction temperature of the method for preparing the compound of formula X may be above 50°C, for example above 80°C, such as 90 to 100°C.
[0234] According to the preparation method of the present invention, the preparation method M10C comprises preparing compound 10 by reacting compound 9 as follows:
[0235]
[0236] The present invention also provides the compound of the above formula IX, for example, compound 9.
[0237] The present invention also provides the use of the above-mentioned compound of formula IX (eg compound 9) in preparing a compound of formula X (eg compound 10).
[0238] According to an embodiment of the present invention, the compound of formula IX can also be prepared from the compound of formula IIIA as a raw material. For example, the compound of formula IIIA can be reacted with phosphorus oxychloride to obtain the following compound of formula IV:
[0239]
[0240] Among them, D, L 10 PG 3 , L 3a Independently have the definitions given above.
[0241] According to an embodiment of the present invention, the reaction of the compound of formula IIIA with phosphorus oxychloride can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is selected from dimethyl sulfoxide or N,N-dimethylformamide.
[0242] According to an embodiment of the present invention, in the above preparation method, the molar ratio of the compound of formula IIIA to phosphorus oxychloride can be 1:2 to 1:8, for example 1:3 to 1:6, such as 1:4 to 1:5.
[0243] According to an embodiment of the present invention, the group L of the compound of formula IV can be synthesized according to known organic synthesis methods. 3a Derivatized to the group E defined above, for example, L 3aConverted into a hydroxy-derived intermediate and then derivatized into group E.
[0244] Alternatively, referring to the above-mentioned preparation method M14, the group L of the compound of formula IV 3a Derivatized to group E.
[0245] Alternatively, according to an embodiment of the present invention, the compound of formula IV or the above derivative may be reacted with trifluoroacetic acid with reference to the above preparation method M15 to make the group PG 3 Derivatized to a hydroxyl group; and / or the above-mentioned derivative can be reacted with the above-mentioned sulfonylating agent with reference to the above-mentioned preparation method M16 to obtain a C in which the hydrogen atom on the hydroxyl group is unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens. 1-6 Alkylsulfonyl, such as methanesulfonyl (Ms) or trifluoromethanesulfonyl substituted derivatives.
[0246] As an example, a compound of formula IV can be reacted with trifluoroacetic acid to obtain a compound of formula XXIII as follows:
[0247]
[0248] Among them, D, L 10 , L 3a Independently have the definitions given above.
[0249] According to an embodiment of the present invention, the compound of formula XXIII can be reacted with hydrazine (such as hydrazine hydrate) with reference to the preparation method M11 described above to obtain the compound of formula XXXI:
[0250]
[0251] Among them, D, L 3a Independently have the definitions given above.
[0252] According to an embodiment of the present invention, the group L of the compound of formula XXXI can be synthesized according to known organic synthesis methods. 3a Derivatized to the group E defined above, for example, L 3a Conversion to a hydroxy-derived intermediate, and then derivatization to group E, gives a compound of formula XXIX:
[0253]
[0254] Alternatively, referring to the above-mentioned preparation method M14, the group L of the compound of formula XXXI 3a Derivatization to group E affords compounds of formula XXIX.
[0255] According to an embodiment of the present invention, the above-mentioned preparation method M16 can also be referred to, and the above-mentioned compound of formula XXIX is reacted with the above-mentioned sulfonylating agent to obtain the following group in which the hydrogen atom on the hydroxyl group is unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 halogens: C 1-6 Alkylsulfonyl, C 1-6 Alkylbenzenesulfonyl, such as methanesulfonyl (Ms-), trifluoromethanesulfonyl (Tf-), p-toluenesulfonyl (Ts-) substituted compounds of formula XXX:
[0256]
[0257] Wherein, D and E independently have the definitions as described above;
[0258] L 30 is the following group which is unsubstituted or substituted by 1, 2, 3, 4, 5 or 6 halogens: C 1-6 Alkylsulfonyl, C 1-6 Alkylbenzenesulfonyl groups, such as methanesulfonyl (Ms-), trifluoromethanesulfonyl (Tf-), p-toluenesulfonyl (Ts-).
[0259] According to an embodiment of the present invention, compound 3a can be used to prepare compound 4, compound 5, compound 6, compound 7, compound 8 and / or compound 9 by the following reaction:
[0260]
[0261] According to an embodiment of the present invention, compound 3a can also be used to prepare compound 4, compound 23, compound 31, compound 29 and / or compound 30 by the following reaction:
[0262]
[0263] According to an embodiment of the present invention, compound 4 can also be used to prepare compound 23, compound 31, compound 25, compound 26, compound 27, compound 28, compound 29 and / or compound 30 by the following reaction:
[0264] The present invention also provides the above-mentioned compounds of formula IV (e.g., compound 4), compounds of formula XXIII (e.g., compound 23), compounds of formula XXXI (e.g., compound 31), compounds of formula XXIX (e.g., compound 29) and compounds of formula XXX (e.g., compound 30), as well as the use of any of the above-mentioned compounds in the preparation of compounds of formula I.
[0265] According to an embodiment of the present invention, there is also provided a method M19B for preparing a compound of formula XIX, comprising reacting a compound of formula XXX with a compound of formula XVIII to obtain a compound of formula XIX, wherein the compound of formula XVIII and the compound of formula XIX have the definitions described above.
[0266] According to an embodiment of the present invention, the preparation method of the compound of formula XIX can be carried out in the presence of a base.
[0267] The base can be an organic base or an inorganic base, for example:
[0268] An organic base selected from the group consisting of a tertiary amine, a substituted or unsubstituted pyridine, and a substituted or unsubstituted triethylamine, trimethylamine, N,N-diisopropylethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-hexylamine, tricyclohexylamine, N-methylcyclohexylamine, N-methylpyrrolidine, N-methylpyrrolidone, N-methylpiperidine, N-ethylpiperidine, N,N-dimethylaniline, N-methylmorpholine, pyridine, 2,3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 2,6-dimethylpyridine, pyridine, 2,4,6-trimethylpyridine, 4-dimethylaminopyridine, quinoline, methylquinoline, N,N,N,N-tetramethylethylenediamine, N,N-dimethyl-1,4-diazacyclohexane, N,N-diethyl-1,4-diazacyclohexane, 1,8-bis(dimethylamino)naphthalene, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), butylimidazole, methylimidazole, sodium tert-butoxide, potassium tert-butoxide; or
[0269] An inorganic base selected from the group consisting of alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates and bicarbonates, such as sodium amide, sodium hydride, lithium diisopropylamide, sodium methoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate and cesium carbonate.
[0270] According to an embodiment of the present invention, the preparation method of the compound of formula XIX can be carried out in the presence of an organic solvent or a mixed solvent of an organic solvent and water. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is an organic solvent such as 1,2-dimethyl-2-nitropropane, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidine, octyl pyrrolidine, octyl caprolactam, 1,3-dimethyl-2-imidazolidinedione, N-formyl piperidine or N,N'-1,4-diformyl piperazine); nitriles (such as acetonitrile, propionitrile, n-butyronitrile, isobutyronitrile or benzonitrile); alcohols (such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol or tert-butanol); ketones (such as acetone, N-methylpyrrolidone). Preferably, the organic solvent is dioxane.
[0271] According to an embodiment of the present invention, the preparation method of the compound of formula XIX can be carried out in the presence of a catalyst, and the catalyst can be a palladium catalyst, such as Pd(dba)2, PdCl2, Pd(OAc)2, Pd(dppf)Cl2, Pd2(dba)3, PdCl2(CH3CN)2, Pd(PPh3)4, PdCl2(PPh3)2, Pd(t-Bu)3, PdCl2(PPh3)2·CH2Cl2, Pd(OAc) / PPh3, PdCl2[(Pet3)]2, Pd(DIPHOS)2, Pd(P ... dCl2(Bipy), [PdCl(Ph2PCH2PPh2)]2, PdCl2[P(o-Tol)3]2, Pd2(dba)3 / P(o-Tol)3, Pd2(dba) / P(furyl)3, PdCl2[P(furyl)3]2, PdCl2(PMePh2)2, PdCl2[P(4-F-Ph)3]2, PdCl2[P(C6F6)3]2, PdCl2[P(2-COOH-Ph)(Ph)2]2, PdCl2[P(4-COOH-Ph)(Ph)2]2.
[0272] According to an embodiment of the present invention, the reaction temperature of the method for preparing the compound of formula XIX can be above 80°C, for example above 100°C, such as 120°C.
[0273] According to an embodiment of the present invention, in the method for preparing the compound of formula XIX, the molar ratio of the compound of formula XXX to the compound of formula XVIII can be 1:1 to 1:5, for example, 1:2 to 1:4, such as 1:3.
[0274] According to an embodiment of the present invention, in the method for preparing the compound of formula XIX, the molar ratio of the compound of formula XXX to the base can be 1:1 to 1:10, for example 1:4 to 1:8, such as 1:5 to 1:6.
[0275] According to an embodiment of the present invention, in the method for preparing the compound of formula XIX, the molar ratio of the compound of formula XXX to the catalyst may be 1:0.01 to 1:0.2, such as 1:0.05 to 1:0.1.
[0276] The present invention also provides a preparation method M1B for a compound of formula I, wherein the preparation method comprises reacting a compound of formula XXX with a compound of formula XXXX to obtain a compound of formula I:
[0277]
[0278] Among them, D, E, L 30 , X 1 , X 2 , X 3, X 4 , G, R k Independently of each other have the definitions given above.
[0279] According to an embodiment of the present invention, the reaction of the preparation method M1B can be carried out in the presence of a catalyst, and the catalyst can be a palladium catalyst, such as Pd(dba)2, PdCl2, Pd(OAc)2, Pd(dppf)Cl2, Pd2(dba)3, PdCl2(CH3CN)2, Pd(PPh3)4, PdCl2(PPh3)2, Pd(t-Bu)3, PdCl2(PPh3)2·CH2Cl2, Pd(OAc) / PPh3, PdCl2[(Pet3)]2, Pd(DIPHOS)2, Pd Cl2(Bipy), [PdCl(Ph2PCH2PPh2)]2, PdCl2[P(o-Tol)3]2, Pd2(dba)3 / P(o-Tol)3, Pd2(dba) / P(furyl)3, PdCl2[P(furyl)3]2, PdCl2(PMePh2)2, PdCl2[P(4-F-Ph)3]2, PdCl2[P(C6F6)3]2, PdCl2[P(2-COOH-Ph)(Ph)2]2, PdCl2[P(4-COOH-Ph)(Ph)2]2.
[0280] According to an embodiment of the present invention, the reaction of the above-mentioned preparation method M1B may be performed in the presence of a base.
[0281] The base can be an organic base or an inorganic base, for example:
[0282] An organic base selected from the group consisting of a tertiary amine, a substituted or unsubstituted pyridine, and a substituted or unsubstituted triethylamine, trimethylamine, N,N-diisopropylethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-hexylamine, tricyclohexylamine, N-methylcyclohexylamine, N-methylpyrrolidine, N-methylpyrrolidone, N-methylpiperidine, N-ethylpiperidine, N,N-dimethylaniline, N-methylmorpholine, pyridine, 2,3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 2,6-dimethylpyridine, pyridine, 2,4,6-trimethylpyridine, 4-dimethylaminopyridine, quinoline, methylquinoline, N,N,N,N-tetramethylethylenediamine, N,N-dimethyl-1,4-diazacyclohexane, N,N-diethyl-1,4-diazacyclohexane, 1,8-bis(dimethylamino)naphthalene, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), butylimidazole, methylimidazole, sodium tert-butoxide, potassium tert-butoxide; or
[0283] An inorganic base selected from the group consisting of alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates and bicarbonates, such as sodium amide, sodium hydride, lithium diisopropylamide, sodium methoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate and cesium carbonate.
[0284] According to an embodiment of the present invention, the reaction of the preparation method M1B can be carried out in the presence of an organic solvent. The organic solvent can be selected from one of the following and a mixture of two or more thereof: ethers (e.g., ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenethyl ether, cyclohexyl methyl ether, dimethyl ether, diethyl ether, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, and epoxy ethane and / or propylene oxide polyethers); sulfoxides (for example tetrahydrodioxythiophene and dimethyl sulfoxide, tetramethyl sulfoxide, dipropyl sulfoxide, benzyl methyl sulfoxide, diisobutyl sulfoxide, dibutyl sulfoxide or diisoamyl sulfoxide); sulfones (for example dimethyl sulfone, diethyl sulfone, dipropyl sulfone, dibutyl sulfoxide, diphenyl sulfone, dihexyl sulfone, methyl ethyl sulfone, ethyl propyl sulfone, ethyl isobutyl sulfone and cyclopentyl sulfone); aliphatic, cycloaliphatic or aromatic hydrocarbons (for example pentane, hexane, heptane, octane, nonane, cyclopentane); hexane, methylcyclohexane, petroleum ether, naphtha, octane, benzene, toluene or xylene); halogenated alkanes (for example dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane); halogenated aromatic compounds (for example chlorobenzene or dichlorobenzene); amides (for example hexamethylphosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methyl Preferably, the organic solvent is an organic solvent such as 1,2-dimethyl-2-nitropropane, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidine, octyl pyrrolidine, octyl caprolactam, 1,3-dimethyl-2-imidazolidinedione, N-formyl piperidine or N,N'-1,4-diformyl piperazine); nitriles (such as acetonitrile, propionitrile, n-butyronitrile, isobutyronitrile or benzonitrile); alcohols (such as methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol or tert-butanol); ketones (such as acetone, N-methylpyrrolidone). Preferably, the organic solvent is dioxane.
[0285] According to an embodiment of the present invention, the reaction of the preparation method M1B may be performed at 100°C to 150°C, for example, 115°C to 125°C.
[0286] According to an embodiment of the present invention, the preparation method M1B comprises preparing compound 1 by reacting compound 30 with compound 40 as follows:
[0287]
[0288] The present invention also provides use of the compound of formula XXX in preparing a compound of formula XIX.
[0289] The present invention also provides a method for preparing the compound of formula I, its pharmaceutically acceptable salt, or the above intermediate, comprising the above preparation method using the compound of formula IIIA and / or the compound of formula IIIB as raw materials or the reaction carried out therein.
[0290] The present invention also provides the use of the compound of formula IIIA in preparing the compound of formula I, its pharmaceutically acceptable salt, or the above intermediate.
[0291] According to a preferred embodiment of the present invention, any one of the preparation methods or uses described above can be carried out under an inert atmosphere (such as a nitrogen atmosphere).
[0292] According to a preferred embodiment of the present invention, in any of the preparation methods or uses described above, the compound as a raw material can be provided in the form of its acid addition salt and participate in the reaction as required.
[0293] According to a preferred embodiment of the present invention, in any of the preparation methods or uses described above, when the compound as a raw material is provided in the form of an acid addition salt and participates in the reaction, if necessary, the acid addition salt can be liberated with a base (organic base or inorganic base) defined above and then participate in the reaction, or the liberation step and the subsequent reaction can be carried out in situ by a "one-pot method".
[0294] The present invention also provides a preparation method, comprising combining one, two, three or more of the above preparation methods as a sequential method to prepare the target compound. It should be understood by those skilled in the art that when one, two, three or more of the above preparation methods are combined as a sequential method, it is preferred to react the product obtained by one preparation method as a raw material for the next preparation method.
[0295] The present invention also provides a preparation method M-IIIB-I, comprising the above-mentioned preparation methods M13, M10A, M11, M19A, M20 and M1A, or a combination of two, three or more of the above-mentioned preparation methods. Preferably, the preparation methods in the combination are carried out sequentially, so that the product obtained by the first preparation method is used as the reaction substrate of the subsequent preparation method.
[0296] The present invention also provides a preparation method M-IIIA-X1, comprising the above-mentioned preparation methods M14, M15, M16, M17 and M10B, or a combination of two, three or more of the above-mentioned preparation methods. Preferably, the preparation methods in the combination are carried out sequentially, so that the product obtained by the first preparation method is used as the reaction substrate of the subsequent preparation method.
[0297] The present invention also provides a preparation method M-IIIA-X2, comprising preparing a compound of formula IV, a compound of formula V, a compound of formula VI, a compound of formula VII, a compound of formula VIII, and a compound of formula IX by the above preparation method, and preparing a compound of formula X by the preparation method M10C.
[0298] The present invention also provides a preparation method M-IIIA-XXX, comprising preparing a compound of formula XXIII, a compound of formula XXXI, a compound of formula XXIX and a compound of formula XXX by the above method.
[0299] According to the embodiments of the present invention, it should be understood that one of the different preparation methods for preparing the same intermediate can be combined with a preparation method for further preparing other compounds using the intermediate as a reaction substrate, and such a combination should also be understood as the content recorded in this specification, and should not be limited to the reaction route formed by combining a certain specific preparation method described above. For example, in the content described above, the preparation method of the compound of formula X includes M10A, M10B and M10C, any of which can be combined with the preparation method M19A, or further combined with M20 and / or M1. Similarly, the different preparation methods of the compound of formula XXX described above can be combined with the preparation method M1B to prepare the compound of formula I.
[0300] According to an embodiment of the present invention, in any of the preparation methods or uses described above, preferably no chromatography such as column chromatography is used to separate or purify the raw materials, reaction products or intermediates.
[0301] According to an embodiment of the present invention, in any of the preparation methods or uses described above, it is preferred that hydrogen is not used as a hydrogenation or reduction agent, and hydrogen is not used in a catalytic hydrogenation manner for the reaction.
[0302] According to an embodiment of the present invention, in any of the preparation methods or uses described above, when an organic solvent or a mixed solvent of an organic solvent and water is used, it is inert to reaction substrates and reagents.
[0303] Definition and explanation of terms
[0304] Unless otherwise specified, the definitions of groups and terms recorded in the specification and claims of this application, including their definitions as examples, exemplary definitions, preferred definitions, definitions recorded in tables, definitions of specific compounds in examples, etc., can be arbitrarily combined and combined with each other. The group definitions and compound structures after such combination and combination shall fall within the scope recorded in the specification of this application.
[0305] Unless otherwise specified, the numerical ranges recorded in this specification and claims are equivalent to recording at least each specific integer value therein. For example, the numerical range "1-40" is equivalent to recording each integer value in the numerical range "1-10", namely 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and each integer value in the numerical range "11-40", namely 11, 12, 13, 14, 15, ..., 35, 36, 37, 38, 39, 40. It should be understood that in the one, two or more used herein when describing substituents, "more" should refer to an integer ≥ 3, such as 3, 4, 5, 6, 7, 8, 9 or 10.
[0306] The term "halogen" denotes a substituent group selected from fluorine, chlorine, bromine or iodine.
[0307] The term "C 1-40 "Alkyl" is understood to mean preferably a straight-chain or branched saturated monovalent hydrocarbon group having 1 to 40 carbon atoms. For example, "C 1-6 The term "alkyl" refers to straight-chain and branched alkyl groups having 1, 2, 3, 4, 5 or 6 carbon atoms. The alkyl group is, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2-methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl, or the like or isomers thereof.
[0308] The term "C 2-40 "Alkenyl" is understood to mean preferably a linear or branched monovalent hydrocarbon radical containing one or more double bonds and having 2 to 40 carbon atoms, preferably "C 2-6 "C 2-6 "Alkenyl" is understood to mean preferably a straight-chain or branched monovalent hydrocarbon radical which contains one or more double bonds and has 2, 3, 4, 5 or 6 carbon atoms, in particular 2 or 3 carbon atoms ("C 2-3"alkenyl"), it being understood that, in the case where the alkenyl contains more than one double bond, the double bonds may be separated from one another or conjugated. The alkenyl is, for example, vinyl, allyl, (E)-2-methylvinyl, (Z)-2-methylvinyl, (E)-but-2-enyl, (Z)-but-2-enyl, (E)-but-1-enyl, (Z)-but-1-enyl, pent-4-enyl, (E)-pent-3-enyl, (Z)-pent-3-enyl, -enyl, (E)-pent-2-enyl, (Z)-pent-2-enyl, (E)-pent-1-enyl, (Z)-pent-1-enyl, hex-5-enyl, (E)-hex-4-enyl, (Z)-hex-4-enyl, (E)-hex-3-enyl, (Z)-hex-3-enyl, (E)-hex-2-enyl, (Z)-hex-2-enyl, (E)-hex-1-enyl, (Z)-hex-1-enyl, isopropenyl, 2-hexenyl, (E)-pent-2-enyl, (Z)-pent-2-enyl, (E)-pent-1-enyl, (Z)-pent ...1-enyl, (Z)-pent-1-enyl, isopropenyl, 2-hexenyl, (E)-pent-2- -methylprop-2-enyl, 1-methylprop-2-enyl, 2-methylprop-1-enyl, (E)-1-methylprop-1-enyl, (Z)-1-methylprop-1-enyl, 3-methylbut-3-enyl, 2-methylbut-3-enyl, 1-methylbut-3-enyl, 3-methylbut-2-enyl, (E)-2-methylbut-2-enyl, (Z)-2-methylbut-2-enyl, (E)-1-methylbut-2-enyl 1-ethylprop-1-enyl, 1-propylvinyl, and 1-isopropylvinyl.
[0309] The term "C 2-40The term "alkynyl" is understood as meaning a straight-chain or branched monovalent hydrocarbon radical which contains one or more triple bonds and has 2 to 40 carbon atoms, preferably a "C2-C6-alkynyl radical". The term "C2-C6-alkynyl" is understood as preferably meaning a straight-chain or branched monovalent hydrocarbon radical which contains one or more triple bonds and has 2, 3, 4, 5 or 6 carbon atoms, in particular 2 or 3 carbon atoms ("C2-C3-alkynyl"). The C2-C6-alkynyl radical is, for example, ethynyl, prop-1-ynyl, prop-2-ynyl, but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylprop-2-ynyl, 2-methylbut-3-ynyl, 1-methyl 1-methylbut-3-ynyl, 1-methylbut-2-ynyl, 3-methylbut-1-ynyl, 1-ethylprop-2-ynyl, 3-methylpent-4-ynyl, 2-methylpent-4-ynyl, 1-methylpent-4-ynyl, 2-methylpent-3-ynyl, 1-methylpent-3-ynyl, 4-methylpent-2-ynyl, 1-methylpent-2-ynyl, 4-methylpent-1-ynyl, 3-methylpent-1-ynyl , 2-ethylbut-3-ynyl, 1-ethylbut-3-ynyl, 1-ethylbut-2-ynyl, 1-propylprop-2-ynyl, 1-isopropylprop-2-ynyl, 2,2-dimethylbut-3-ynyl, 1,1-dimethylbut-3-ynyl, 1,1-dimethylbut-2-ynyl or 3,3-dimethylbut-1-ynyl. In particular, the alkynyl is ethynyl, prop-1-ynyl or prop-2-ynyl.
[0310] The term "C 3-40 "Cycloalkyl" is understood to mean a saturated monovalent monocyclic, bicyclic hydrocarbon ring or bridged cycloalkane having 3 to 40 carbon atoms, preferably "C 3-10 The term "Cycloalkyl" 3-10 "Cycloalkyl" is understood to mean a saturated monovalent monocyclic, bicyclic hydrocarbon ring or a bridged cycloalkane having 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms. 3-10 The cycloalkyl group may be a monocyclic hydrocarbon group such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl or cyclodecyl, or a bicyclic hydrocarbon group such as a decalin ring.
[0311] The term "3-20 membered heterocyclyl" means a saturated monovalent monocyclic, bicyclic hydrocarbon ring or bridged cycloalkane, which contains 1-5 heteroatoms independently selected from N, O and S, and the total number of ring atoms is 3-20 (such as 3, 4, 5, 6, 7, 8, 9, 10, etc.), and is preferably a "3-10 membered heterocyclyl". The term "3-10 membered heterocyclyl" means a saturated monovalent monocyclic, bicyclic hydrocarbon ring or bridged cycloalkane, which contains 1-5, preferably 1-3 heteroatoms independently selected from N, O and S, such as 1, 2, 3 heteroatoms independently selected from N, O and S. The heterocyclyl may be attached to the rest of the molecule via any of the carbon atoms or the nitrogen atom (if present). In particular, the heterocyclic group may include, but is not limited to, a 4-membered ring, such as azetidinyl, oxetanyl; a 5-membered ring, such as tetrahydrofuranyl, dioxolyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, pyrrolinyl; or a 6-membered ring, such as tetrahydropyranyl, piperidinyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl or trithianyl; or a 7-membered ring, such as diazepanyl. Optionally, the heterocyclic group may be benzo-fused. The heterocyclic group may be bicyclic, such as, but not limited to, a 5,5-membered ring, such as a hexahydrocyclopenta [c] pyrrole-2 (1H) -yl ring, or a 5,6-membered bicyclic ring, such as a hexahydropyrrolo [1,2-a] pyrazine-2 (1H) -yl ring. The ring containing the nitrogen atom may be partially unsaturated, i.e., it may contain one or more double bonds, such as but not limited to 2,5-dihydro-1H-pyrrolyl, 4H-[1,3,4]thiadiazinyl, 4,5-dihydrooxazolyl or 4H-[1,4]thiazinyl, or it may be benzo-fused, such as but not limited to dihydroisoquinolinyl. According to the present invention, the heterocyclic group is non-aromatic. When the 3-20-membered heterocyclic group is connected with other groups to form the compound of the present invention, the carbon atom on the 3-20-membered heterocyclic group may be connected with other groups, or the heterocyclic atom on the 3-20-membered heterocyclic group may be connected with other groups. For example, when the 3-20-membered heterocyclic group is selected from piperazinyl, the nitrogen atom on the piperazinyl may be connected with other groups. Or when the 3-20-membered heterocyclic group is selected from piperidinyl, the nitrogen atom on the piperidinyl ring and the carbon atom on the para position thereof may be connected with other groups.
[0312] The term "C 6-20 "Aryl" is understood to mean preferably a monovalent aromatic or partially aromatic monocyclic, bicyclic or tricyclic hydrocarbon ring having 6 to 20 carbon atoms, preferably "C 6-14 The term "C 6-14 The term "aryl" is understood to mean preferably a monovalent aromatic or partially aromatic monocyclic, bicyclic or tricyclic hydrocarbon ring ("C 6-14or a ring having 9 carbon atoms ("C9 aryl"), for example indanyl or indenyl, or a ring having 10 carbon atoms ("C 10 aryl), such as tetrahydronaphthyl, dihydronaphthyl or naphthyl, or a ring having 13 carbon atoms ("C 13 aryl), such as fluorenyl, or a ring having 14 carbon atoms ("C 14 aryl”), such as anthracenyl. When the C 6-20 When the aryl group is substituted, it may be monosubstituted or polysubstituted. Also, there is no limitation on the substitution position, for example, it may be substituted at the ortho position, para position or meta position.
[0313] The term "5-20 membered heteroaryl" is understood to include monovalent monocyclic, bicyclic or tricyclic aromatic ring systems having 5 to 20 ring atoms and containing 1 to 5 heteroatoms independently selected from N, O and S, for example "5-14 membered heteroaryl". The term "5-14 membered heteroaryl" is understood to include monovalent monocyclic, bicyclic or tricyclic aromatic ring systems having 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 ring atoms, in particular 5 or 6 or 9 or 10 carbon atoms, and containing 1 to 5, preferably 1 to 3 heteroatoms each independently selected from N, O and S and, in addition, in each case may be benzo-fused. In particular, the heteroaryl group is selected from thienyl, furanyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, thiadiazolyl, thia-4H-pyrazolyl and the like and benzo derivatives thereof, such as benzofuranyl, benzothienyl, benzoxazolyl, benzisoxazolyl, benzimidazolyl, benzotriazolyl, indazolyl, indolyl, isoindolyl and the like; or pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl and the like and benzo derivatives thereof, such as quinolyl, quinazolinyl, isoquinolyl and the like; or azinyl, indolizinyl, purinyl and the like and benzo derivatives thereof; or cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, phenoxazinyl and the like. When the 5-20 membered heteroaryl is connected to other groups to form the compound of the present invention, the carbon atom on the 5-20 membered heteroaryl ring may be connected to other groups, or the heteroatom on the 5-20 membered heteroaryl ring may be connected to other groups. When the 5-20 membered heteroaryl is substituted, it may be monosubstituted or polysubstituted. In addition, there is no limitation on the substitution site, for example, the hydrogen connected to the carbon atom on the heteroaryl ring may be substituted, or the hydrogen connected to the heteroatom on the heteroaryl ring may be substituted.
[0314] Unless otherwise specified, heterocyclic groups, heteroaryls or heteroarylene groups include all possible isomeric forms thereof, such as positional isomers thereof. Thus, for some illustrative non-limiting examples, forms substituted or bonded to other groups at one, two or more positions of the 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11-, 12-positions, etc. (if present), may include pyridin-2-yl, pyridin-2-ylene, pyridin-3-yl, pyridin-3-ylene, pyridin-4-ylene and pyridin-4-ylene; thienyl or thienylene groups include thien-2-yl, thien-2-ylene, thien-3-ylene and thien-3-ylene; pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl.
[0315] The term "oxo" refers to a substituent in which a carbon atom, a nitrogen atom or a sulfur atom is oxidized to form an oxy group (=O).
[0316] Unless otherwise stated, the definitions of terms herein also apply to groups containing the term, e.g. 1-6 The definition of alkyl also applies to C 1-6 Alkyloxy, -N(C 1-6 Alkyl)2, -NHC 1-6 Alkyl or -S(O)2-C 1-6 Alkyl, etc.
[0317] It will be appreciated by those skilled in the art that the compounds of Formula I may exist in the form of various pharmaceutically acceptable salts. If these compounds have a basic center, they may form acid addition salts; if these compounds have an acidic center, they may form a base addition salt; if these compounds contain both an acidic center (e.g., a carboxyl group) and a basic center (e.g., an amino group), they may also form an internal salt.
[0318] The compounds of the present invention may exist in the form of solvates (e.g. hydrates), wherein the compounds of the present invention contain polar solvents as structural elements of the crystal lattice of the compounds, in particular water, methanol or ethanol. The amount of polar solvents, in particular water, may exist in a stoichiometric or non-stoichiometric ratio.
[0319] According to their molecular structure, the compounds of the present invention may be chiral and therefore may exist in various enantiomeric forms. These compounds may thus exist in racemic form or in optically active form. The compounds of the present invention or their intermediates may be separated into enantiomeric compounds by chemical or physical methods known to those skilled in the art, or used in this form for synthesis. In the case of racemic amines, diastereomers are prepared from the mixture by reaction with optically active resolution agents. Examples of suitable resolution agents are optically active acids, such as tartaric acid, diacetyltartaric acid, dibenzoyltartaric acid, mandelic acid, malic acid, lactic acid, suitable N-protected amino acids (e.g. N-benzoylproline or N-phenylsulfonylproline) or various optically active camphorsulfonic acids in the R and S forms. Chromatographic enantiomer resolution may also be advantageously performed with the aid of optically active resolution agents (e.g. dinitrobenzoylphenylglycine, cellulose triacetate or other carbohydrate derivatives or chiral derivatized methacrylate polymers immobilized on silica gel). Suitable eluents for this purpose are aqueous or alcoholic solvent mixtures, for example hexane / isopropanol / acetonitrile.
[0320] The term "tautomer" refers to functional group isomers resulting from the rapid movement of an atom in a molecule between two positions. The compounds of the present invention may exhibit tautomerism. Tautomeric compounds may exist in two or more interconvertible species. Prototropic tautomers arise from the migration of a covalently bonded hydrogen atom between two atoms. Tautomers generally exist in equilibrium, and attempts to separate a single tautomer usually produce a mixture whose physicochemical properties are consistent with a mixture of compounds. The position of equilibrium depends on the chemical characteristics within the molecule. For example, in many aliphatic aldehydes and ketones such as acetaldehyde, the keto form predominates; while in phenols, the enol form predominates. The present invention encompasses all tautomeric forms of the compounds.
[0321] The corresponding stable isomers can be separated according to known methods, for example by extraction, filtration or column chromatography.
[0322] Beneficial Effects
[0323] The preparation method of the invention does not use separation and purification steps of column chromatography such as silica gel column chromatography, and does not use hydrogen as a hydrogenation or reduction reagent, thereby significantly improving production efficiency and safety.
[0324] Furthermore, the preparation method of the present invention realizes the efficient utilization of positional isomers IIIA and IIIB, avoiding the adverse effect of abandoning positional isomer IIIA on the yield of the target product. More surprisingly, the total yield of the method using positional isomer IIIA is as high as 9.4%, which is even significantly higher than the yield of less than 4% when positional isomer IIIB is used, and when the two positional isomers are simultaneously used in the preparation of compound I, the yield is increased by more than 3 times compared with the case of using positional isomer IIIB alone.
[0325] Therefore, the preparation method of the present invention can synthesize the compound of formula I and its intermediates in high yield, low cost and in an environmentally friendly manner, thereby enabling the compound of formula I to be produced on an industrial scale. DETAILED DESCRIPTION
[0326] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.
[0327] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.
[0328] Example 1: Preparation of Compound 3a and Compound 3b
[0329] (1) 2,4,6-Trimethylbenzenesulfonic acid 1-amino-3-bromo-5-(4-methoxybenzyloxy)pyridin-1-ium (Compound 1)
[0330]
[0331] In the reactor, add trifluoroacetic acid (340kg), replace with nitrogen three times, cool to 0-10℃, add N-Boc-O-2,4,6-trimethylbenzenesulfonylhydroxylamine (90kg, 285mol) in batches under nitrogen protection, release a large amount of gas after each batch, react for 2h, add water to quench the reaction, precipitate solid, dissolve the solid with dichloromethane, wash with NaHCO3 aqueous solution until the organic phase pH is about 7, and separate. The organic phase is then cooled to 0-10℃ under nitrogen protection, and 3-bromo-5-(4-methoxybenzyloxy)pyridine (64kg, 217mol) is added in batches at 0-10℃, and filtered after reacting for 1-2h to obtain 89kg of product. 1H-NMR (400MHz, DMSO-d6): δ.8.67-8.72(m,2H),8.58(brs,2H),8.34(d,1H),7.43(d,2H),7 .00(d,2H),6.75(s,2H),5.23(s,2H),3.78(s,3H),2.51(s,6H),2.17(s,3H),m / z=311[M+1] + .
[0332] (2) 6-bromo-2-fluoro-4-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine (Compound 3a) and 4-bromo-2-fluoro-6-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine (Compound 3b)
[0333]
[0334] Add 188 kg of tetrahydrofuran to the reactor, then add 2,4,6-trimethylbenzenesulfonic acid 1-amino-3-bromo-5-(4-methoxybenzyloxy)pyridin-1-ium (91 kg, 179 mol) and p-toluenesulfonic acid 2,2-difluorovinyl ester (51 kg, 218 mol), slowly add 1,8-diazacyclo[5,4,0]undecene-7 (109 kg, 717 mol), react at room temperature for 1 hour after the addition, add dichloromethane (560 kg), then add saturated ammonium chloride solution (240 kg), wash the organic phase with water (210 kg), dry over anhydrous sodium sulfate, concentrate under reduced pressure, and recrystallize from acetonitrile to obtain 35 kg of 6-bromo-2-fluoro-4-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine, 1 H-NMR (400MHz, DMSO-d6): δ8.59(s,1H),7.43-7.46(m,2H),7.07(s,1H),6.97-7.00(m,2H),6.39(d,1H),5.22(s,2H),3.78(s,3H),m / z=351[M+1] + ; 4-bromo-2-fluoro-6-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine 8.2 kg, 1 H-NMR (400MHz, DMSO-d6): δ8.50-8.51(m,1H),7.64(d,1H),7.39-7.45(m,2H), 6.95-6.99(m,2H),6.33-6.34(m,1H),5.05(s,2H),3.77(d,3H),m / z=351[M+1] + .
[0335] Example 2: Preparation of Compound 11
[0336] (1) 4-Bromo-2-fluoro-6-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 12)
[0337]
[0338] Add 4-bromo-2-fluoro-6-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine (7.4 kg, 21 mol) and DMF (21 kg) to the reaction kettle in sequence, replace nitrogen three times, control the temperature at 0-10°C, add phosphorus oxychloride (8.0 kg, 52 mol) dropwise, heat to 20-30°C, react for 17 hours, and the obtained product solution can be directly used in the next reaction. 1 H-NMR (400MHz, DMSO-d6): δ10.50(s,1H),8.80(d,1H),8.08(d,1H),7.39-7.43(m,2H),6.95-6.99(m,2H),5.12(s,2H),3.77(s,3H).m / z=379[M+1] + .
[0339] (2) 4-Bromo-2-fluoro-6-hydroxypyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 13)
[0340]
[0341] The reaction liquid in the previous step reactor was heated to 70°C, and HPLC sampling was monitored until the raw materials reacted completely. The reaction liquid was cooled to 25°C and added to 66 kg of water, kept at 30°C and stirred for 2 hours, filtered, and the filter cake was slurried with 17 kg of dichloromethane for 1 hour, and filtered again to obtain the filter cake. After vacuum drying, 4.7 kg of the product was obtained. 1 H-NMR (400MHz, DMSO-d6): δ10.62(brs,1H),10.46(d,1H),8.32(t,1H),7.80(s,1H).m / z=259[M+1] + .
[0342] (3) 4-Bromo-6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 10)
[0343]
[0344] Add 4-bromo-2-fluoro-6-hydroxypyrazole [1,5-a] pyridine-3-carboxaldehyde (4.7kg, 18mol), dimethyl sulfoxide (15.5kg), potassium carbonate (2.8kg, 20mol), iodoethane (3.0kg, 19mol) to the reactor in sequence, replace nitrogen three times, heat to 65℃ for reaction, HPLC sampling and monitoring until the raw materials react completely, cool to 25℃, add 47kg water to the reactor, stir at 25-30℃ for 1h and then extract to dryness. Add 47kg water to the reactor, stir at 25-30℃ for 1h and then filter to dryness. Add acetonitrile (9.0kg) to the reactor, add the filter cake to the reactor, stir at 25-30℃ for 1-2h, filter to dryness, and vacuum dry to obtain 4.6kg of product. 1 H-NMR (400MHz, DMSO-d6): δ10.49(s,1H),8.69(d,1H),8.00(d,1H),4.16(q,2H),1.37(t,3H).m / z=287[M+1] + .
[0345] (4) Synthesis of 4-bromo-6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (Compound 11)
[0346]
[0347] Add 4-bromo-6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine-3-carboxaldehyde (4.6 kg, 16 mol), dimethyl sulfoxide (46 L), 85% hydrazine hydrate (4.7 kg) into the reaction kettle, heat to 110-115 ° C for reaction, monitor by HPLC until the reaction is complete, cool to 30-40 ° C, add water (138 L), keep warm and stir for 1-2 hours, filter, and vacuum dry the filter cake to obtain 4.0 kg of the product. 1 H-NMR (400MHz, DMSO-d6): δ12.81(brs,1H),8.64(s,1H),7.92(s,1H),7.58(s,1H),4.11-4.17(m,2H),1.35-1.38(t,3H).m / z=281[M+1]+.
[0348] Example 3: Preparation of Compound I
[0349] (1) 3-(5-(6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-4-yl)pyridin-2-yl)-3,6-diazabicyclo[3.3.1]heptane-6-carbonic acid tert-butyl ester (Compound 19)
[0350]
[0351] To the reaction flask, 4-bromo-6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (30 g, 0.11 mol), 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)pyridin-2-yl)-3,6-diazabicyclo[3.3.3]heptane-6-carbonate tert-butyl ester (57 g, 0.14 mol), bistriphenylphosphine palladium dichloride (1.5 g, 2.2 mmol), lithium carbonate (16 g, 0.22 mol), 300 mL of dioxane, and 150 mL of water were added in sequence. Nitrogen was replaced three times, and the reaction was heated at 85°C for 20 hours. The mixture was filtered through diatomaceous earth, and the filtrate was poured into 3 L of water to obtain a solid. 1.2 L of tetrahydrofuran was used to dissolve the solid, 60 g of SILICYCLE silica gel was added, the mixture was heated at 60 ° C and stirred for 12 hours, cooled to room temperature, and the silica gel was removed by diatomaceous earth filtration. The filtrate was concentrated under reduced pressure to about 100 mL, 300 mL of methyl tert-butyl ether was added, and the mixture was concentrated under reduced pressure to about 100 mL again. This step was repeated 2 or more times, the mixture was stirred at room temperature overnight, the mixture was filtered, the filter cake was rinsed with a small amount of methyl tert-butyl ether, and the solid was dried in vacuo to obtain 42.3 g of the product with an HPLC purity of 98.8%. 1 H-NMR (400MHz, DMSO-d6): δ12.64(s,1H),8.62(d,2H),8.51(d,2H),8.08(q,1H),7.55(s,1H),7.26(d,1H),6.90(d,1H),4.20 -4.26(m,2H),4.15-4.19(m,2H),4.03-4.09(m,2H),2.60(d,1H),1.53(d,1H),1.38-1.42(m,3H),1.30(s,9H).m / z=476[M+1] + .
[0352] (2) 4-(6-(3,6-diazabicyclo[3.1.1]heptane-3-yl)pyridin-3-yl)-6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (Compound 20)
[0353]
[0354] To the reaction flask, tert-butyl 3-(5-(6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-4-yl)pyridin-2-yl)-3,6-diazabicyclo[3.3.1]heptane-6-carbonate (30 g, 0.063 mol), 500 mL of methanol, and concentrated sulfuric acid (25 g, 0.25 mol) were added in sequence. The mixture was heated to 60°C and reacted for 12 h. The methanol was removed by concentration under reduced pressure. 500 mL of methyl tert-butyl ether was added to slurry and the product was filtered to obtain 43 g with HPLC purity of 99.5%, which was directly used in the next step. 1 H NMR (400MHz, DMSO-d6): δ12.67(s,1H),8.62(d,1H),8.50(d,1H),8.07(q,1H),7.59(s,1H),7.23(d,1H),6 .84(d,1H),4.15-4.20(m,2H),3.66-3.73(m,6H),3.18(s,1H),2.56-2.57(m,1H),1.49(d,1m / z=376[M+1] + .
[0355] (3) 6-ethoxy-4-(6-(6-((6-methoxypyridin-3-yl)methylene)-3,6-diazabicyclo[3.3.1]heptane-3-yl)pyridin-3-yl)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (Compound I)
[0356]
[0357] The product of step (2) (30 g), 6-methoxy-3-pyridinecarboxaldehyde (20 g, 0.14 mol), 2-methylpyridine-N-borane (16 g, 0.15 mol), triethylamine (34 mL, 0.24 mol), and 650 mL of n-propanol were added to the reaction flask in sequence, and the mixture was reacted at room temperature for 18 hours. 300 mL of dichloromethane was added, and the mixture was washed once with a saturated ammonium chloride solution and twice with water. The mixture was concentrated under reduced pressure, and 300 mL of methanol was added. The mixture was heated to reflux and reduced to 400 °C. The mixture was heated to 40-45°C, 160 mL of methyl tert-butyl ether was slowly added, the temperature was lowered to 25°C and stirred for 12 hours, 160 mL of methyl tert-butyl ether was added and stirred for 1 hour, the mixture was concentrated under reduced pressure to about 160 mL, 300 mL of methyl tert-butyl ether was added, and the mixture was concentrated under reduced pressure to about 160 mL again. This step was repeated 2 or more times, the mixture was stirred at room temperature overnight, the mixture was filtered, the filter cake was rinsed with a small amount of methyl tert-butyl ether, and the solid was dried in vacuo to obtain 19 g of the product with HPLC purity of 98.9%. 1H-NMR (400MHz, DMSO-d6): δ12.64(brs,1H),8.64(s,1H),8.51(s,1H),8.08-8.1 1(m,2H),7.69(d,1H),7.63(s,1H),7.26(s,1H),6.90(d,J=8.8Hz,1H),6.77(d,J =8.8Hz,1H),4.16-4.21(m,2H),3.83(s,3H),3.76-3.79(m,2H),3.68(s,2H),3.5 3-3.59(m,4H),2.53-2.56(m,1H),1.56-1.58(m,1H),1.40(t,3H).m / z=497[M+1] + .
[0358] Example 4: Preparation of Compound 11
[0359] (1) 6-ethoxy-2-fluoro-4-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine (Compound 14)
[0360]
[0361] Add ethanol (500mL), 6-bromo-2-fluoro-4-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine (52.5g, 150.0mmol), cuprous iodide (570mg, 3.0mmol), sodium tert-butoxide (43.2g, 450mmol) and N1,N2-bis(4-hydroxy-2,6-dimethylphenyl)oxamide (1.0g, 3.0mmol) to the reaction bottle in sequence. The reaction solution was heated to 80℃ under nitrogen protection for 16 hours. After cooling, water (150mL) was added to the reaction solution with stirring and stirred for 30 minutes. The solid was filtered and vacuum dried to obtain 37g of the product. 1 H-NMR (400MHz, DMSO-d6): δ7.91(s,1H),7.41(d,J=11.2Hz,2H),6.97(d,J=11.2Hz,2H),6.69(s, 1H),6.19(s,1H),5.18(s,2H),3.98-4.03(m,2H),3.76(s,3H),1.32-1.36(t,3H).m / z=317[M+1] + .
[0362] (2) 6-Ethoxy-2-fluoropyrazolo[1,5-a]pyridin-4-ol (Compound 15)
[0363]
[0364] Add dichloromethane (450mL) and 6-ethoxy-2-fluoro-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine (37g, 117.0mmol) to the reaction flask in sequence. Add trifluoroacetic acid (45mL) dropwise and react for 3 hours. The reaction solution is washed with water (300mL) and saturated brine (150mL) and then concentrated to obtain a crude product solution (about 60mL). Add n-heptane (250mL) to the above crude product solution, stir for 1 hour, filter, and vacuum dry to obtain 16.5g of the product. 1 H-NMR (400MHz, DMSO-d6): δ10.78(s,1H),7.81(s,1H),6.33(s,1H),6.16(s,1H),3.94-4.00(m,2H),1.35-1.39(t,3H).m / z=197[M+1] + .
[0365] (3) 6-Ethoxy-2-fluoropyrazolo[1,5-a]pyridin-4-yl trifluoromethanesulfonate (Compound 16)
[0366]
[0367] Add dichloromethane (200mL) and 6-ethoxy-2-fluoropyrazolo[1,5-a]pyridin-4-ol (14.8g, 75.5mmol) to the reaction flask in sequence. Add a dichloromethane (50mL) solution of triethylamine (11.5g, 113.3mmol) and trifluoromethanesulfonic anhydride (23.4g, 83.1mmol) and react at room temperature for 16 hours. The reaction solution was washed with water (200mL) and saturated brine (100mL) and concentrated to obtain a crude product. Add DMF (150mL) to the crude product and slowly pour into water (1000mL) under stirring. After stirring for 30 minutes, filter, wash with water, and air dry at 60℃ for 16 hours to obtain 6-ethoxy-2-fluoropyrazolo[1,5-a]pyridin-4-yl trifluoromethanesulfonate (23.4g, yield 95%) as a light yellow solid. 1 H-NMR (400MHz, DMSO-d6): δ8.56(s,1H),7.60(s,1H),6.48(s,1H),4.08-4.13(m,2H),1.34-1.38(t,3H).m / z=329[M+1] + .
[0368] (4) 4-Bromo-6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine (Compound 17)
[0369]
[0370] Add NMP (60 mL), 6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine-4-trifluoromethanesulfonate (6.6 g, 20.0 mmol), pentamethylcyclopentadienyl triphenylphosphine ruthenium (II) chloride (800 mg, 1.0 mmol) and LiBr (2.6 g, 30.0 mmol) to the reaction bottle in sequence. Replace nitrogen three times, raise the temperature to 90 ° C and react for 16 hours. Slowly pour the reaction solution into water (800 mL) and stir for 1 hour, filter, wash with water, and vacuum dry the solid to obtain 3.9 g of the product. 1 H-NMR (400MHz, DMSO-d6): δ8.40(s,1H),7.56(s,1H),6.32(s,1H),4.03-4.08(m,2H),1.32-1.35(t,3H).m / z=259[M+1] + .
[0371] (5) 4-Bromo-6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 10)
[0372]
[0373] DMF (60 mL), 4-bromo-6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine (3.5 g, 13.5 mmol) and POCl3 (8.3 g, 54 mmol) were added to the reaction bottle in sequence and reacted at room temperature for 48 hours. The reaction solution was slowly poured into water (600 mL) and stirred for 1 hour, filtered, washed with water, and the solid was vacuum dried to obtain 4.2 g of the product. 1 H-NMR (400MHz, DMSO-d6): δ10.49(s,1H),8.69(s,1H),8.00(s,1H),4.10-4.16(m,2H),1.30-1.34(t,3H).m / z=287[M+1] + .
[0374] (6) 4-Bromo-6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (Compound 11)
[0375]
[0376] The operation is the same as step (4) of Example 2.
[0377] Example 5: Preparation of Compound 30
[0378] (1) 6-Bromo-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-4-ol (Compound 31)
[0379]
[0380] Add DMSO (200mL), acetic hydrazide (8.6g, 115.8mmol) and 6-bromo-2-fluoro-4-hydroxypyrazolo[1,5-a]pyridine-3-carboxaldehyde (20.0g, 77.2mmol) to the reaction bottle in sequence, and heat to 140℃ for 6 hours with 80% hydrazine hydrate aqueous solution (24.1g, 386mmol). After cooling, the reaction solution is slowly poured into water (2000mL) and extracted twice with ethyl acetate (1000mL), washed with water (400mL), washed with saturated brine (400mL), and dried over anhydrous sodium sulfate. The organic phase is concentrated under reduced pressure to obtain 10.5g of the product. 1 H-NMR (400MHz, DMSO-d6): δ12.68(brs,1H),11.35(s,1H),8.67(s,1H),7.61(s,1H),6.84(s,1H).m / z=253 / 255[M+1] + .
[0381] (2) 6-Ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-4-ol (Compound 29)
[0382]
[0383] Add ethanol (50 mL), 6-bromo-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine-4-ol (2 g, 8 mmol), cuprous iodide (160 mg, 8 mmol), cesium carbonate (8 g, 24 mmol) and 8-hydroxyquinoline (240 mg, 1.6 mmol) to the sealed reaction bottle. Heat to 100°C and react for 4 days. Stop the reaction and add 200 mL of dioxane. Heat to reflux. Filter with diatomaceous earth while hot. Concentrate the filtrate to about 50 mL under reduced pressure, then pour into 500 mL of water.
[0384] The solid was filtered and dried in vacuo to obtain 1.5 g of the product. 1 H-NMR (400MHz, DMSO-d6): δ12.51(brs,1H),11.02(brs,1H),8.06(s,1H),7.80(s,1H),6.48(s,1H),4.02-4.08(m,2H),1.35(t,3H).m / z=219[M+1] + .
[0385] (3) 6-Ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine-4-trifluoromethanesulfonate (Compound 30)
[0386]
[0387] Add 6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine-4-ol (250 mg, 0.68 mmol), diisopropylethylamine (264 mg, 2.0 mmol) and DMF (5 mL) to the reaction bottle, cool to 5°C and add 1,1,1-trifluoro-N-phenyl-N-((trifluoromethyl)sulfonyl)methanesulfonamide (183 mg, 0.51 mmol). React at room temperature for 2 hours, pour the reaction solution into 200 mL of water, filter to obtain a solid, and dry to obtain 200 mg of the product with an HPLC purity of 97.5%. 1 H-NMR (400MHz, DMSO-d6): δ12.98(brs,1H),8.77(s,1H),7.85(s,1H),7.59(s,1H),4.15-4.21(m,2H),1.38(t,3H).m / z=351[M+1] + .
[0388] Example 6: Preparation of Compound 30
[0389] (1) 6-Bromo-2-fluoro-4-hydroxypyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 23)
[0390]
[0391] Add dichloromethane (15 mL) and 6-bromo-2-fluoro-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine-3-carbaldehyde (1.1 g, 3.0 mmol) to the reaction flask in sequence. Add trifluoroacetic acid (3 mL) dropwise and stir at room temperature for 3 hours. Concentrate under reduced pressure to obtain 0.6 g of the product. 1 H-NMR (400MHz, DMSO-d6): δ11.97(s,1H),10.03(s,1H),8.76(s,1H),7.14(s,1H).m / z=259[M+1] + .
[0392] (2) 6-Bromo-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-4-ol (Compound 31)
[0393]
[0394] Add DMSO (200 mL), acetic hydrazide (8.6 g, 115.8 mmol), 6-bromo-2-fluoro-4-hydroxypyrazolo[1,5-a]pyridine-3-carboxaldehyde (20.0 g, 77.2 mmol), 80% hydrazine hydrate (24.1 g, 386 mmol) to the reaction bottle in sequence, and heat to 110°C for 12 hours. After the reaction solution is cooled, slowly pour it into water (2000 mL), filter it, and vacuum dry the solid to obtain 10.5 g of the product. 1 H-NMR (400MHz, DMSO-d6): δ12.68(brs,1H),11.35(s,1H),8.67(s,1H),7.61(s,1H),6.84(s,1H).m / z=253[M+1] + .
[0395] (3) 6-Bromo-4-(4-methoxybenzyloxy)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (Compound 25)
[0396]
[0397] Add 6-bromo-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine-4-ol (5.0 g, 20.0 mmol), 1-(chloromethyl)-4-methoxybenzene (3.4 g, 22.0 mmol), potassium carbonate (8.3 g, 60.0 mmol) and DMF (50 mL) to the reaction bottle in sequence. Heat the reaction solution to 40°C and react for 16 hours. After the reaction solution is cooled, slowly pour it into water (500 mL) with stirring. After stirring for 1 hour, filter it with suction, wash it with water, and dry it to obtain 3.7 g of the product. 1 H-NMR (400MHz, DMSO-d6): δ12.78(brs,1H),8.81(s,1H),7.83(s,1H),7.48(d,J=8.4Hz ,2H),7.24(s,1H),6.94(d,J=8.4Hz,2H),5.33(s,2H),3.77(s,3H).m / z=373 / 375[M+1] + .
[0398] (4) 4-(4-methoxybenzyloxy)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-6-ol (Compound 27)
[0399]
[0400] 6-Bromo-4-(4-methoxybenzyloxy)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (3.7 g, 10.0 mmol), bipyranolide borate (3.8 g, 15.0 mmol), potassium acetate (2.9 g, 30.0 mmol), PdCl2(dppf) (731 mg, 1.0 mmol) and 1,4-dioxane (70 mL) were added to the reaction flask in sequence. The reaction solution was heated to 90°C under nitrogen protection for 16 hours. The solution was filtered with diatomaceous earth while hot, and the filtrate was concentrated under reduced pressure to obtain the crude product of 4-(4-methoxybenzyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine. THF (70 mL) was added to the crude product, cooled to 5°C in an ice bath, and 30% H2O2 (6.5 mL) was added dropwise. The mixture was warmed to room temperature and reacted for 1.5 hours. Ethyl acetate (150 mL) was added to the reaction solution, and the mixture was filtered with suction. The filtrate was washed with 0.1N hydrochloric acid aqueous solution (50 mL), washed twice with water (40 mL), washed with saturated brine (40 mL), dried over anhydrous sodium sulfate, and the organic phase was concentrated under reduced pressure to obtain 900 mg of the product. 1 H-NMR (400MHz, DMSO-d6): δ12.50(brs,1H),9.83(s,1H),7.88(s,1H),7.69(s,1H),7.48(d ,J=8.4Hz,2H),6.99(d,J=8.4Hz,2H),6.70(s,1H),5.28(s,2H),3.79(s,3H).m / z=311[M+1] + .
[0401] (5) 6-Ethoxy-1-ethyl-4-(4-methoxybenzyloxy)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (Compound 28)
[0402]
[0403] 4-(4-methoxybenzyloxy)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine-6-ol (680mg, 2.2mmol), K2CO3 (911mg, 6.6mmol), iodoethane (378mg, 2.4mmol) and DMF (15mL) were added to the reaction bottle in sequence. The reaction solution was heated to 30°C and reacted for 16 hours. The reaction solution was slowly poured into water (150mL), stirred for 0.5 hours, filtered, washed with water, and dried to obtain a crude product. The crude product was added with 10mL 1,4-dioxane and heated to dissolve, 10mL methyl tert-butyl ether was slowly added, cooled to room temperature, concentrated to 5mL, and then 20mL methyl tert-butyl ether was added. Stir for 12 hours, filter and dry to obtain 227mg of the product as a yellow solid. H 1 -NMR (400MHz, DMSO-d6): δ12.53(brs,1H),8.16(s,1H),7.73(s,1H),7.46(d,J=8.4Hz,2H),6.99(d, J=8.4Hz,2H),6.82(s,1H),5.31(s,2H),4.06-4.12(m,2H),3.77(s,3H),1.37(t,3H).m / z=339[M+1] + .
[0404] (6) 6-Ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-4-ol (Compound 29)
[0405]
[0406] 6-ethoxy-1-ethyl-4-((4-methoxybenzyl)oxy)-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine (230 mg, 0.68 mmol) and dichloromethane (15 mL) were added to the reaction flask in sequence. Trifluoroacetic acid (0.5 mL) was added, and the reaction solution was stirred at room temperature for 16 hours. After concentration, 250 mg of the product was obtained, which was directly used in the next step. 1 H-NMR (400MHz, DMSO-d6): δ12.51(brs,1H),11.02(brs,1H),8.06(s,1H),7.80(s,1H),6.48(s,1H),4.02-4.08(m,2H),1.35(t,3H).m / z=219[M+1] + .
[0407] (7) 6-Ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine-4-trifluoromethanesulfonate (Compound 30)
[0408]
[0409] Referring to step (3) of Example 5, compound 30 was prepared.
[0410] Example 7: Preparation of Compound 19
[0411] 3-(5-(6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridin-4-yl)pyridin-2-yl)-3,6-diazabicyclo[3.3.1]heptane-6-carbonic acid tert-butyl ester (Compound 19)
[0412]
[0413] 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)pyridin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carbonate tert-butyl ester (60 mg, 0.15 mmol), 6-ethoxy-1H-pyrazolo[3',4':3,4]pyrazolo[1,5-a]pyridine-4-trifluoromethanesulfonate (35 mg, 0.05 mmol), PdCl2(dppf) (4 mg, 0.005 mmol), potassium fluoride (18 mg, 0.3 mmol) and 1,4-dioxane (0.5 mL) were added to the reaction bottle in sequence. The temperature was raised to 120°C under nitrogen protection for 16 hours. After the organic phase was concentrated, 50 mL of methyl tert-butyl ether was added for pulping and the product was filtered to obtain 12 mg. m / z=476[M+1] + .
[0414] Example 8: Preparation of Compound 10
[0415] 4-Bromo-6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 10)
[0416] (1) 6-Bromo-2-fluoro-4-(4-methoxybenzyloxy)pyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 4)
[0417]
[0418] DMF (35 mL) and 6-bromo-2-fluoro-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine (3.5 g, 10.0 mmol) were added to the reaction bottle in sequence, the temperature was lowered to 5°C, POCl3 (6.1 g, 40.0 mmol) was added dropwise, and then stirred at room temperature for 48 hours. The reaction solution was slowly poured into water (350 mL) and stirred for 1 hour, filtered, and the solid was vacuum dried to obtain 3.6 g of the product. 1H-NMR (400MHz, DMSO-d6): δ10.01(s,1H),8.88(s,1H),7.59(s,1H),7.47(d, J=8.8Hz,2H),7.01(d,J=8.8Hz,2H),5.34(s,2H),3.78(s,3H).m / z=379[M+1] + .
[0419] (2) 2-Fluoro-4-((4-methoxybenzyl)oxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 5)
[0420]
[0421] Add 6-bromo-2-fluoro-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine-3-carboxaldehyde (7.6 g, 20.0 mmol), bipyranol borate (5.6 g, 22.0 mmol), potassium acetate (5.9 g, 60.0 mmol), PdCl2(dppf) (1.5 g, 2.0 mmol) and 1,4-dioxane (100 mL) to the reaction bottle in sequence. Replace nitrogen three times, heat to 85 °C and react for 16 hours. Filter the reaction solution through diatomaceous earth, and concentrate the filtrate under reduced pressure to obtain 8.6 g of the product, which is directly used in the next step. m / z=465[M+1] + .
[0422] (3) 2-Fluoro-6-hydroxy-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 6)
[0423]
[0424] Add 2-fluoro-4-((4-methoxybenzyl)oxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxaldehyde (4.3g, 10.1mmol) and 1,4-dioxane (110mL) to the reaction bottle, cool to 5°C in an ice bath and add 30% H2O2 (4mL) dropwise. Warm the reaction solution to room temperature and react for 2 hours. Add 200mL of dichloromethane, wash with 50mL of water, NaHSO3 solution (50mL) and saturated brine (50mL) in turn, and dry over anhydrous sodium sulfate. Concentrate the organic phase to a volume of 10mL, add 100mL of methyl tert-butyl ether, and filter to obtain 2.1g of the product. 1H-NMR (400MHz, DMSO-d6): δ10.27(s,1H),9.97(s,1H),7.84(s,1H),7.47(d,J=8.4H z,2H),7.06(s,1H),7.00(d,J=8.4Hz,2H),5.28(s,2H),3.78(s,3H).m / z=317[M+1] + .
[0425] (4) 6-Ethoxy-2-fluoro-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 7)
[0426]
[0427] 2-Fluoro-6-hydroxy-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine-3-carboxaldehyde (2.0 g, 6.3 mmol), K2CO3 (1.8 g, 12.6 mmol), iodoethane (1.2 g, 7.6 mmol) and DMF (19 mL) were added to the reaction bottle in sequence. The reaction solution was heated to 40 degrees and reacted for 3 hours. The reaction solution was poured into 400 mL of water and extracted with 100 mL × 3 dichloromethane. The filtrate was concentrated to a volume of 10 mL, 100 mL of methyl tert-butyl ether was added, and the solution was concentrated under reduced pressure to about 10 mL. 100 mL of methyl tert-butyl ether was added, and the solution was concentrated under reduced pressure to about 10 mL again. This step was repeated twice to obtain 1.25 g of the product. 1 H-NMR (400MHz, DMSO-d6): δ10.07(s,1H),8.20(s,1H),7.47(d,J=8.4Hz,2H),7.18(s,1H),7.00 (d,J=8.4Hz,2H),5.32(s,2H),4.07-4.12(m,2H),3.78(s,3H),1.32-1.39(t,3H).m / z=345[M+1] + .
[0428] (5) 6-Ethoxy-2-fluoro-4-hydroxypyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 8)
[0429]
[0430] 6-ethoxy-2-fluoro-4-((4-methoxybenzyl)oxy)pyrazolo[1,5-a]pyridine-3-carboxaldehyde (450 mg, 1.3 mmol) and 30 mL of dichloromethane were added to the reaction flask in sequence. Trifluoroacetic acid (2 mL) was added dropwise and reacted at room temperature for 2 hours. The mixture was concentrated under reduced pressure to a volume of 10 mL, 100 mL of methyl tert-butyl ether was added, the mixture was concentrated under reduced pressure to about 10 mL, 100 mL of methyl tert-butyl ether was added, and the mixture was concentrated under reduced pressure to about 10 mL again. This step was repeated twice to obtain 305 mg of the product. 1 H-NMR (400MHz, DMSO-d6): δ11.59(s,1H),9.85(s,1H),8.15(s,1H),6.83(s,1H),4.04-4.09(m,2H),1.30-1.36(t,3H).m / z=225[M+1] + .
[0431] (6) 6-Ethoxy-2-fluoro-3-formylpyrazolo[1,5-a]pyridine-4-trifluoromethanesulfonate (Compound 9)
[0432]
[0433] Add 6-ethoxy-2-fluoro-4-hydroxypyrazolo[1,5-a]pyridine-3-carboxaldehyde (315 mg, 1.4 mmol), diisopropylethylamine (362 mg, 2.8 mmol) and DMF (5 mL) to the reaction bottle, cool to 5 ° C and add 1,1,1-trifluoro-N-phenyl-N-((trifluoromethyl)sulfonyl)methanesulfonamide (660 mg, 1.7 mmol). The reaction solution is warmed to room temperature and reacted for 2 hours. Pour the reaction solution into 200 mL of water, extract with 100 mL × 3 dichloromethane, dry over anhydrous sodium sulfate, and concentrate the organic phase to obtain 430 mg of the product, which is directly used in the next step. 1 H-NMR (400MHz, DMSO-d6): δ9.89(s,1H),8.85(s,1H),7.89(s,1H),4.17-4.22(m,2H),1.32-1.38(t,3H).m / z=357[M+1] + .
[0434] (7) 4-Bromo-6-ethoxy-2-fluoropyrazolo[1,5-a]pyridine-3-carbaldehyde (Compound 10)
[0435]
[0436] Add NMP (0.5 mL), 6-ethoxy-2-fluoro-3-formylpyrazolo[1,5-a]pyridine-4-trifluoromethanesulfonate (5 mg, 0.015 mmol), tris(acetonitrile)pentamethylcyclopentadiene trifluoromethanesulfonate ruthenium (II) (1.0 mg, 0.002 mmol) and LiBr (4 mg, 0.045 mmol) to the reaction bottle in sequence. Replace nitrogen three times, heat to 100 ° C and react for 2 hours. Pour the reaction solution into 100 mL of water, extract with 100 mL × 3 dichloromethane, dry with anhydrous sodium sulfate, and separate the organic phase by column chromatography to obtain 2 mg of the product. 1 H-NMR (400MHz, DMSO-d6): δ10.49(s,1H),8.69(s,1H),8.00(s,1H),4.10-4.16(m,2H),1.30-1.34(t,3H).m / z=287[M+1] + .
[0437] The above describes the exemplary embodiments of the present invention. It should be understood that the protection scope of the present application is not limited to the above exemplary embodiments. Any modifications, equivalent substitutions, variations, etc. made by those skilled in the art within the spirit and principle of the present invention should be included in the protection scope of the claims of the present application.
Claims
1. A method for preparing a compound of formula I, comprising step M1A: reacting a compound of formula XX with R k -C(O)-H reaction to obtain a compound of formula I: in: X 1 , X 3 The same or different, independently selected from CR 1 ; X 2 is N; X 4 Selected from CR 1 or N; Each R 1 are the same or different and are independently selected from H, halogen, CN, NH2, OH, C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkyloxy, C 3-6 Cycloalkyloxy; D is selected from H, halogen, CN, NH2, OH, C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkyloxy, C 3-6 Cycloalkyloxy; E is selected from unsubstituted or optionally substituted with one, two or more R c Substituted C 1-6 Alkyloxy; each R c are the same or different and are independently selected from halogen, CN, OH, oxo (=O), C 1-6 Alkyl, C 1-6 Alkyloxy, C 3-6 Cycloalkyl, 3-10 membered heterocyclic group, C 6-10 Aryl, 5-7 membered heteroaryl, C 3-6 Cycloalkyloxy, 3-8 membered heterocyclyloxy; G is selected from unsubstituted or optionally substituted with one, two or more R e substituted 5-9 membered heterocyclyl; R k is selected from unsubstituted or optionally substituted with one, two or more R g Substituted with the following groups: C 6-10 Aryl, 5-10 membered heteroaryl; Every R e The same or different, independently selected from C 1-6 Alkyl, C 1-6 Alkyloxy; Every R g The same or different, independently selected from CN, OH, C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkyloxy, halogenated C 1-6 Alkyl, halogenated C 1-6 Alkyloxy; The preparation method further comprises step M20: removing PG from the compound of formula XIX 19 Reaction under the conditions of , to obtain a compound of formula XX: PG 19 One selected from tert-butyloxycarbonyl, cyclobutyloxycarbonyl, benzyloxycarbonyl, p-methoxybenzylcarbonyl, 2-biphenyl-2-propyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, phthalimide, p-toluenesulfonyl, trifluoroacetyl, (9H-fluoren-9-ylmethoxy)carbonyl, benzyl, 4-methoxybenzyl, diphenylmethyl, 2-(trimethylsilyl)ethoxycarbonyl, adamantyloxycarbonyl, formyl, and acetyl; The preparation method further comprises step M19A: reacting the compound of formula XI with the compound of formula XVIII to obtain the compound of formula XIX: L 11 is selected from the following groups which are halogen, unsubstituted or substituted by 1, 2, 3, 4, 5 or 6 halogens: C 1-6 Alkylsulfonyloxy, C 1-6 Alkylbenzenesulfonyloxy; The preparation method further comprises step M11: reacting the compound of formula X with hydrazine hydrate to obtain a compound of formula XI: L 10 is selected from F, Cl, Br or I; The preparation method further comprises step M10A: reacting the compound of formula XIII with compound R 21 -L 13 Reaction to obtain a compound of formula X: L 13 Selected from the following groups which are unsubstituted or substituted by 1, 2, 3, 4, 5 or 6 halogens: C 1-6 Alkylsulfonyloxy, C 1-6 Alkylbenzenesulfonyloxy, or F, Cl, Br or I; R 21 is selected from unsubstituted or optionally substituted with one, two or more R c Substituted C 1-6 alkyl; The preparation method further comprises step M13: reacting the compound of formula IIIB in the presence of phosphorus oxychloride, wherein the compound of formula IIIB has the following structure: PG 3 unsubstituted or optionally substituted with 1, 2, 3, 4 or 5 selected from C 1-6 Alkyl, C 1-6 The following groups substituted by alkyloxy, halogen: benzyl, C 1-6 Alkyl, tri(C 1-6 alkyl)silyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, allyl, triphenylmethyl, C 1-6 Alkyloxymethyl, benzyloxymethyl, C 1-6 Alkylcarbonyl, haloC 1-6 Alkylcarbonyl, benzoyl.
2. The preparation method according to claim 1, characterized in that: In step M20, the PG is removed 19 The conditions for removing PG in the presence of acid 19 The acid is selected from one, two or more of hydrochloric acid, sulfuric acid, formic acid and acetic acid.
3. The preparation method according to claim 2, characterized in that: The molar ratio of the compound of formula XIX to the acid is from 1:1 to 1:
5.
4. The preparation method according to claim 1, characterized in that: Step M19A is carried out in the presence of a catalyst selected from the group consisting of Pd(dba)2, PdCl2, Pd(OAc)2, Pd(dppf)Cl2, Pd2(dba)3, PdCl2(CH3CN)2, Pd(PPh3)4, PdCl2(PPh3)2, Pd(t-Bu)3, PdCl2(PPh3)2·CH2Cl2, Pd(OAc) / PPh3, PdCl2[(Pet3)]2, Pd(DIPHOS)2, PdCl2(Bipy), [Pd Cl(Ph2PCH2PPh2)]2, PdCl2[P(o-Tol)3]2, Pd2(dba)3 / P(o-Tol)3, Pd2(dba) / P(furyl)3, PdCl2[P(furyl)3]2, PdCl2(P MePh2)2, PdCl2[P(4-F-Ph)3]2, PdCl2[P(C6F6)3]2, PdCl2[P(2-COOH-Ph)(Ph)2]2, PdCl2[P(4-COOH-Ph)(Ph)2]2; The molar ratio of the compound of formula XI to the catalyst is 1:0.001 to 1:0.
05.
5. The preparation method according to claim 1, characterized in that: Step M19A is carried out in the presence of a base; The molar ratio of the compound of formula XI to the base is from 1:1 to 1:
5.
6. The preparation method according to claim 1, characterized in that: In step M19A, the molar ratio of the compound of formula XI to the compound of formula XVIII is 1:1 to 1:
2.
7. The preparation method according to claim 1, characterized in that: In step M11, the molar ratio of the compound of formula X to hydrazine hydrate is 1:1 to 1:
15.
8. The preparation method according to claim 1, characterized in that: In step M10A, the compound of formula XIII and compound R 21 -L 13 The molar ratio is 1:1 to 1:
2.
9. The preparation method according to claim 1, characterized in that: L 11 Selected from methanesulfonyloxy, trifluoromethanesulfonyloxy, p-toluenesulfonyloxy.
10. The preparation method according to claim 1, characterized in that: L 13 is selected from methanesulfonyloxy, trifluoromethanesulfonyloxy, p-toluenesulfonyloxy, F, Cl, Br or I.
11. The preparation method according to claim 1, characterized in that: PG 3 is selected from benzyl, 4-methoxybenzyl, 4-methylbenzyl, 4-chlorobenzyl, 4-bromobenzyl or 2,3,4-trimethoxybenzyl.
12. The preparation method according to claim 1, characterized in that: D is selected from the following groups: H, halogen, -CN, -NH2, 13. The preparation method according to claim 1, characterized in that: E is selected from the following groups:
14. The preparation method according to claim 1, characterized in that: R k is selected from unsubstituted or optionally substituted with one, two or more R g Substituted pyridyl or phenyl.
15. The preparation method according to claim 1, characterized in that: G is selected from a 6-7 membered heterocyclic group having a monocyclic, bicyclic or bridged ring structure, which contains 1, 2 or 3 heteroatoms independently selected from N, O and S.
16. The preparation method according to claim 1, characterized in that: G is selected from 17. The preparation method according to claim 1, characterized in that: R k is selected from unsubstituted or optionally substituted with one, two or more R g Substituted pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridin-5-yl, pyridin-6-yl or phenyl.
18. The preparation method according to claim 1, characterized in that: In the compound of formula I, R k With methylene to form a group selected from the following:
19. The preparation method according to claim 1, characterized in that: In the compound of formula I, R k Selected from 1, 2, 3 or 4 selected from C 1-6 Alkyl and C 1-6 Alkyloxy substituted groups 20. The preparation method according to claim 1, characterized in that: Wherein the compound of formula I is selected from the following compounds:
21. The preparation method according to claim 1, characterized in that: in: The compound of formula XX and R k The reaction of -C(O)-H is carried out in the presence of borane, pyridine borane, 2-methylpyridine borane, sodium borohydride, sodium triacetoxyborohydride, sodium cyanoborohydride; The compound of formula XX and R k The molar ratio of -C(O)-H is 1:1 to 1:5; The molar ratio of the compound of formula XX to borane or 2-methylpyridine borane is 1:1 to 1:5; The molar ratio of the compound of formula XX to the base is 1:1 to 1:5; The reaction temperature of the preparation method of the compound of formula I is 15-50°C.
22. The preparation method according to claim 1, characterized in that: in: The compound of formula XX and R k The reaction of -C(O)-H is carried out in the presence of 2-methylpyridine borane and a base; The compound of formula XX and R k The molar ratio of -C(O)-H is 1:1.1 to 1:1.3; The molar ratio of the compound of formula XX to borane or 2-methylpyridine borane is 1:1.1 to 1:1.3; The molar ratio of the compound of formula XX to the base is 1:1.8 to 1:2.2; The reaction temperature of the preparation method of the compound of formula I is 20-30°C.
23. The preparation method according to claim 1, characterized in that: in: The step M13 comprises preparing compound 12 from compound 3b, and preparing compound 13 from compound 12; The step M10A comprises preparing compound 10 by reacting compound 13 as follows; The step M11 comprises preparing compound 11 by reacting compound 10 as follows; The step M19A comprises reacting compound 11 and compound 18 to prepare compound 19; The step M20 comprises preparing compound 20 by subjecting compound 19 to the following reaction; The step M1A comprises preparing compound 1 by subjecting compound 20 to the following reaction:
24. The preparation method according to claim 1, wherein the compound of formula IIIB is first reacted with phosphorus oxychloride to obtain the compound of formula XII, and then the compound of formula XII is further reacted to obtain the compound of formula XIII, characterized in that: The compound of formula XII has the following structure: Among them, D, L 10 , L 11 PG 3 Independently has the definition in claim 1.
25. The preparation method according to claim 1, characterized in that: The molar ratio of the compound of formula IIIB to phosphorus oxychloride is 1:2 to 1:
4.
26. The preparation method according to claim 25, wherein: The molar ratio of the compound of formula IIIB to phosphorus oxychloride is 1:2.4 to 1:2.5.
Citation Information
Cited By
Method for preparing nitrogen-containing polycyclic fused ring compound, and intermediate and use of compound
WO2023280073A1
